
<?xml version="1.0" encoding="UTF-8"?>
<itemContainer xmlns="http://omeka.org/schemas/omeka-xml/v5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="https://www.globalhealthchronicles.org/items/browse?output=omeka-xml&amp;page=66&amp;sort_field=Dublin+Core%2CTitle" accessDate="2026-05-26T06:32:42-07:00">
  <miscellaneousContainer>
    <pagination>
      <pageNumber>66</pageNumber>
      <perPage>12</perPage>
      <totalResults>2286</totalResults>
    </pagination>
  </miscellaneousContainer>
  <item itemId="5422" public="1" featured="0">
    <fileContainer>
      <file fileId="3539">
        <src>https://www.globalhealthchronicles.org/files/original/9c4eb38b7b33579782dddfac3c43af2f.jpg</src>
        <authentication>e2940ab5a27ebff907d52ec979490dd1</authentication>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64882">
                  <text>Malaria Control: CDC Beginnings</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64883">
                  <text>&lt;div class="landing"&gt;
&lt;p&gt;In 1942, when the U.S. was mobilizing for the Second World War, the U. S. Public Health Service set up a program to protect the personnel of military bases in the Southeastern states from malaria. This disease had long been rampant in the area, and posed serious threats to the health of the military and civilian populations. The program known as Malaria Control in War Areas (MCWA) was created to carry out the work. The lack of space in Washington due to the war effort allowed the program to base its headquarters in Atlanta, Georgia, and closer to the work at hand. During the war years, the program was expanded to include the control of other communicable diseases. Because its work was so successful, a new organization was created around the nucleus of MCWA, the Communicable Disease Center (CDC). The date was July 1, 1946. This archive chronicles the agency’s early history from 1941-1951, including the contributions of local businessmen and Emory University. The buttons to the right will connect you to a searchable database of documents, oral histories, photographs and media. To conduct an advanced search, use the link in the blue navigation bar above. Use of this information is free, but please see &lt;strong&gt;“About this Site”&lt;/strong&gt; for guidance on how to acknowledge the sources of the information used.&lt;/p&gt;
&lt;/div&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="14">
      <name>Media</name>
      <description>Powerpoints, Recorded lectures, movies, training films, and interviews</description>
      <elementContainer>
        <element elementId="86">
          <name>Player</name>
          <description>html for embedded player to stream video content</description>
          <elementTextContainer>
            <elementText elementTextId="65222">
              <text>&lt;iframe width="560" height="315" src="https://www.youtube.com/embed/gWi6YSPzO70" frameborder="0"&gt;&lt;/iframe&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="65218">
                <text>HEALTH EDUCATION MALARIA CONTROL</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="65219">
                <text>Health Education Against Malaria. &#13;
&#13;
A teacher learns the facts about malaria control and mosquito elimination in a health education course sponsored by local, state, and federal public health officials, and later imparts her knowledge to home town groups by lectures, field trips, and individual instruction. &#13;
&#13;
 Black and White&#13;
 TRT :06:11&#13;
&#13;
 Produced by the United States Public Health Service</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="65220">
                <text>U. S. National Library of Medicine, History of Medicine Division, Images and Archives Section at the National Institutes of Health, 8600 Rockville Pike, Bethesda, MD 20894 &#13;
 www.collections.nlm.nih.gov</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="65221">
                <text>1944</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
  <item itemId="8067" public="1" featured="0">
    <fileContainer>
      <file fileId="5767">
        <src>https://www.globalhealthchronicles.org/files/original/03152ec869a41504ee22052dd47e4897.pdf</src>
        <authentication>4089f6b8d98aace678e8491a1c22976e</authentication>
      </file>
    </fileContainer>
    <collection collectionId="7">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64885">
                  <text>HIV/AIDS</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="15">
      <name>Documents</name>
      <description>Government Records</description>
      <elementContainer>
        <element elementId="87">
          <name>Keywords</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="75841">
              <text>March 29, 1985, Darrow, AIDS, homophobia, care, inadequate, insensitive, education, need, empathy, sensitivity, CDC, training experiences, channels, topics, language, skills, nurturing, support, scientifically credible, standardized message,  policy, technical assistance, evaluation  </text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="75837">
                <text>HEALTH EDUCATION: Issue of Homohobia</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="75838">
                <text>Discussions on homophobia, health-workers need to enhance their understanding, empathy, and sensitivity towards high-risk groups. &#13;
</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="75839">
                <text>Bill Darrow Collection </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="75840">
                <text>March 29, 1985</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
  <item itemId="6538" public="1" featured="0">
    <fileContainer>
      <file fileId="4064">
        <src>https://www.globalhealthchronicles.org/files/original/fc977aaa4af0379ecde5363ab37bbe57.pdf</src>
        <authentication>67284144332dff24e4958a5ed48ac54c</authentication>
      </file>
    </fileContainer>
    <collection collectionId="7">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64885">
                  <text>HIV/AIDS</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="15">
      <name>Documents</name>
      <description>Government Records</description>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="69642">
                <text>HEALTH WORKER PRECAUTIONS</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="69643">
                <text>A collection of 5 memos regarding risks to Health-care workers and exposure to blood from AIDS patients and precautions to take. One manuscript on precautions for personnel taking care of patients with AIDS. </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="69644">
                <text>The U. S. National Archives and Records Administration at Atlanta, 5780 Jonesboro Road, Morrow, GA 30260       www.archives.gov/atlanta</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="69645">
                <text>1982-1984</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
  <item itemId="5862" public="1" featured="0">
    <fileContainer>
      <file fileId="3645">
        <src>https://www.globalhealthchronicles.org/files/original/849aab2bcd50143f027792248f1a8022.JPG</src>
        <authentication>e5de2775973929cb628fe608de7802a9</authentication>
      </file>
    </fileContainer>
    <collection collectionId="7">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64885">
                  <text>HIV/AIDS</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="14">
      <name>Media</name>
      <description>Powerpoints, Recorded lectures, movies, training films, and interviews</description>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="66979">
                <text>HEARD MUCH ABOUT AIDS LATELY?</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="66980">
                <text>1991</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="66981">
                <text>America Responds to AIDS [ARTA]&#13;
"Heard much about AIDS lately?" "Barbara: Ask me if I've heard about anything else. Really? So your friends talk about AIDS? Barbara: No, no one does. But, you said you haven't heard anything else. Barbara: I guess they're embarrassed. Are you embarrassed? Barbara: AIDS isn't exactly what you'd call party conversation. No, it's not party. But how are we ever going to prevent AIDS if we can't even talk about it? Barbara: But, how do you talk to someone about AIDS? Just like this." &#13;
&#13;
Prevention; Education; Women; Advocacy;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="66982">
                <text>United States Department of Health and Human Services, Centers for Disease Control and Prevention, America Responds To AIDS</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
  <item itemId="6565" public="1" featured="0">
    <fileContainer>
      <file fileId="4117">
        <src>https://www.globalhealthchronicles.org/files/original/ea4d91d4e47689bbe084c65887cc294c.pdf</src>
        <authentication>d4a451b3cfb67b633452862f07ace1e2</authentication>
      </file>
    </fileContainer>
    <collection collectionId="7">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64885">
                  <text>HIV/AIDS</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="15">
      <name>Documents</name>
      <description>Government Records</description>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="69749">
                <text>HEARING REQUEST</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="69750">
                <text>LETTER&#13;
&#13;
TO: Dr. Mason&#13;
&#13;
FROM: G. V. (Sonny) Montgomery, Chairman of the Subcommittee on Hospitals and Health Care&#13;
Asking Dr. Mason to testify on AIDS policy regarding the Veterans Administration medical system. Attached are budget documents and a Q&amp;A about AIDS programs. </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="69751">
                <text>The U. S. National Archives and Records Administration at Atlanta, 5780 Jonesboro Road, Morrow, GA 30260       www.archives.gov/atlanta</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="69752">
                <text>May 29, 1987 </text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
  <item itemId="8303" public="1" featured="0">
    <fileContainer>
      <file fileId="6207">
        <src>https://www.globalhealthchronicles.org/files/original/6c05648fe0f26c77059d17827e217d2d.JPG</src>
        <authentication>358e2e12533f32430aa346434291156e</authentication>
      </file>
      <file fileId="6208">
        <src>https://www.globalhealthchronicles.org/files/original/f8a83df4dab3a4469049b40b976cfc06.JPG</src>
        <authentication>ee20bee70b9fcdc07126a16e368d7aaf</authentication>
      </file>
    </fileContainer>
    <collection collectionId="8">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64886">
                  <text>Ebola</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="14">
      <name>Media</name>
      <description>Powerpoints, Recorded lectures, movies, training films, and interviews</description>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="77067">
                <text>HELMET – Liberia </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="77068">
                <text>A motorcycle helmet worn by Riders for Health couriers traveling by motorcycle throughout 15 districts for specimen transport during the 2014 – 2016 Ebola response in Liberia.&#13;
&#13;
Riders for Health specializes in supplying, managing, and maintaining vehicles for health-focused organizations in African countries.&#13;
</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="77069">
                <text>United States Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), Riders for Health</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="77070">
                <text>2014 – 2016</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="77071">
                <text>2016.106.008</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
  <item itemId="6577" public="1" featured="0">
    <fileContainer>
      <file fileId="4141">
        <src>https://www.globalhealthchronicles.org/files/original/bf42be937ce9eae9cb9b19cbb7de99f9.pdf</src>
        <authentication>96dd5c27e1ada97265aa001cbc1ba59a</authentication>
      </file>
    </fileContainer>
    <collection collectionId="7">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64885">
                  <text>HIV/AIDS</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="15">
      <name>Documents</name>
      <description>Government Records</description>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="69797">
                <text>HEMOPHILIAC RISKS</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="69798">
                <text>LETTER&#13;
&#13;
TO: Dr. Jeffery A. Koplan &#13;
&#13;
FROM: Dr. Leon W. Hoyer&#13;
Regarding the risks associated to hemophiliacs. </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="69799">
                <text>January 6, 1983</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="69800">
                <text>The U. S. National Archives and Records Administration at Atlanta, 5780 Jonesboro Road, Morrow, GA 30260       www.archives.gov/atlanta</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
  <item itemId="3532" public="1" featured="0">
    <fileContainer>
      <file fileId="3286" order="1">
        <src>https://www.globalhealthchronicles.org/files/original/ee0ead593395bd00bb0f24999ae89aac.jpg</src>
        <authentication>9feba0e305076cbf28b12294cf45b79e</authentication>
      </file>
    </fileContainer>
    <collection collectionId="1">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64878">
                  <text>Smallpox</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64879">
                  <text>&lt;div class="landing"&gt;
&lt;p&gt;Smallpox disease was declared eradicated in 1980, the result of a collaborative global campaign. To date, it is the only disease affecting humans to be eradicated from the world. Global eradication of smallpox ranks among the great achievements of humankind. Gone, through determined human effort, is a disease which has brought death to millions, frequently altering the course of history, and traveling through the centuries to every part of the world.  &lt;/p&gt;
&lt;p&gt;The vital contributions made by the Centers for Disease Control and Prevention are highlighted. Official government correspondence, meeting transcripts, policy statements, surveillance reports and mortality statistics tell a part of that story. Adding depth to these traditional archives are the personal stories of the public health pioneers who worked tirelessly on the frontlines of the smallpox eradication campaign.&lt;/p&gt;
&lt;p&gt;The links above connect you to a database of oral histories, photographs, documents, and other media.&lt;/p&gt;
&lt;p&gt;Use of this information is free, but please see &lt;strong&gt;“About this Site”&lt;/strong&gt; for guidance on how to acknowledge the sources of the information used&lt;/p&gt;
&lt;/div&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="17">
      <name>Moving Image</name>
      <description>A series of visual representations imparting an impression of motion when shown in succession. Examples include animations, movies, television programs, videos, zoetropes, or visual output from a simulation.</description>
      <elementContainer>
        <element elementId="5">
          <name>Transcription</name>
          <description>Any written text transcribed from a sound.</description>
          <elementTextContainer>
            <elementText elementTextId="43075">
              <text>&lt;pre&gt;&lt;strong&gt;
 Interview Transcript
&lt;/strong&gt;
Interview

D.A. Henderson with Paul O'Grady
Transcribed: February 2009



Paul O'Grady:    This is an interview with D. A. Henderson on July 12,  2008
           at the Center for Disease Control  and  Prevention  in  Atlanta,
           Georgia about his  involvement  with  the  smallpox  eradication
           program. The interview is being conducted as a part of a reunion
           marking the 40th anniversary of the program  in  Asia  and  East
           Africa. The interviewer is Paul  O'Grady.  Can  you  state  your
           name?

D.A. Henderson:  D. A. Henderson

Paul O'Grady:     And  you  understand  that  this  oral  history  is  being
           recorded?

D.A. Henderson:  Yes, I do.

Paul O'Grady:    Thank you. I would like to start off by having you give  us
           a little bit about your background, what lead you to a career in
           public health and how you started working for the CDC?

D.A. Henderson:  Well, I was born and brought  up  in  Lakewood,  Ohio  near
           Cleveland. Went to Oberlin College and then to the University of
           Rochester School of  Medicine.  After  internship  at  the  Mary
           Imogene Bassett Hospital in Cooperstown,  I  was  told  that  my
           deferment from the draft was at an  end  and  I  had  my  choice
           either to voluntarily enlist in which case I would  be  a  first
           lieutenant, or be drafted in which case I would  be  a  private.
           So, like many of my colleagues who had been deferred  since,  in
           my case 1946, and this is 1955, I decided I could  volunteer.  I
           was having difficulty making up my mind  whether  it  was  army,
           navy or air force. I figured I am just an intern, all I am going
           to do are boring draft and do physical of new recruits. So about
           this  time  somebody  shows  up  from   something   called   the
           Communicable Disease Center, which I had never  heard  of.  They
           are from the public health service which I knew  nothing  about,
           but they talked about working on  infectious  diseases  which  I
           didn't really much care for. As I  thought  about  it,  well  it
           might be two years and I'd learn something, and as they  pointed
           out we don't wear uniforms, we don't salute, you don't do  basic
           training. I  go,  well,  okay,  doesn't  sound  too  bad.  So  I
           enlisted, in the public health service.

      Now, this was the Epidemic Intelligence Service  which  at  that  time
           was only four years old. That created by Alex  Langmere  at  the
           CDC. There were, however, quite a  number  of  applicants  every
           year who were anxious to do their required time and  service  at
           CDC  would  be  challenging,  interesting,   so   forth.   Well,
           fortunately I had done a history of medicine paper  in  my  last
           year of medical school. Why had a done the history  of  medicine
           paper? Because  they  offered  $200  and  a  handy  subject  was
           something about cholera in upstate New York in  1834  and  there
           was material available in the newspapers and so forth.

      So I spent time creating this paper,  going  through  the  newspapers,
           plotting cases, doing curves. I didn't know what I was doing  in
           terms of training but it really was epidemiology and in fact  it
           turned out to be rather fun. I had to see what the responses  of
           the health department were, to the  various  challenges.  Seeing
           how it spread through the city and so forth. So  in  advertently
           I'd become interested in a subject which we had no courses in at
           all and I got drafted to the public health service. That's where
           I got into public health and I had no interest in public  health
           either at that time. I was going to be in my mind a cardiologist
           and this would be two years  out  and  then  I  go  back  to  my
           residency in cardiology.

Paul O'Grady:    What were the major public health concerns at that time?

D.A. Henderson:  There was one dominant major public health problem at  that
           time or challenge and that was polio myelitis.  There  had  been
           significant cases, significant outbreaks of polio  myelitis.  In
           the 1950s, there was a great deal of fear  at  that  time  about
           polio. In the summers there was - they  closed  swimming  pools,
           parents kept their children away from other children.  If  there
           were outbreaks  there  was  a  great  deal  of  anxiety  in  the
           community. The National Foundation for Infantile Paralysis was a
           very major foundation. It was the only categorical foundation at
           all  that  time.  It  had  been  started  because  of  President
           Roosevelt's, Franklin D. Roosevelt's polio myelitis and they had
           raised for Warm Springs, Georgia rehabilitation center. They had
           been extremely successful and they took some of this  money  and
           they put it into some basic research of very  good  quality  and
           development of the vaccine. There was great anticipation in 1954
           because they began the first major study of the Salk vaccine and
           there was school children across the country. I forget how  many
           were involved. As I recall it's 100,000 plus.

      The results were coming up in April of that year that I was  doing  my
           internship. Very soon thereafter they  began  to,  in  April,  I
           guess they announced the  results  and  they  began  vaccination
           around the country with the vaccine. About this time they  found
           that some of the lots of vaccine were not quite - the virus  was
           not quite as dead as it should be. They began to  get  cases  of
           polio myelitis, paralytic disease caused by the  vaccine.  So  I
           was being inducted into the Center for Disease Control.

      The epidemic intelligence service Alex  Langmere's  group  were  doing
           the work of compiling information on the cases in trying to find
           out which lots of vaccine were involved and trying to  determine
           the magnitude of the problem and then what to do about it. So we
           were totally immersed, as I came into the service on the 1st  of
           July with what was an ongoing investigation into what really was
           the end of the largest field trial ever conducted on  a  vaccine
           and the introduction of the polio myelitis vaccine which  was  -
           had been awaited for so long. At the same time we had  what  was
           amounted to a vaccine incident which was serious with  a  number
           of paralytic cases associated with  the  vaccine.  The  question
           was, was it the vaccine of all companies or  was  it  maybe  one
           company and only some lots of the vaccine or  what  was  it.  So
           this was all absorbing for many of those who came aboard at that
           time.

Paul O'Grady:    And how many years were you at CDC after your - so you  got
           a two year government required service and then you stayed on?

D.A. Henderson:  Well it turned out be  rather  more  exciting  than  I  had
           thought. They had a matching program. So,  that  those  who  are
           recruited you then submitted  your  preferences  on  a  list  of
           different positions you could have. They in turn would  look  at
           the people who are coming in, about 30-35 of us and decide which
           ones they wanted and they would list their priorities  and  then
           they match them up. I matched  up  with  a  position  which  was
           called assistant chief  of  the  epidemic  intelligence  service
           which would be as they called it a go-for job  kind  of  putting
           things together, helping organize a course and doing  things  of
           this sort.

      Well, we would have a course to a one month at that  time  where  they
           taught us epidemiology and  bio  statistics.  Basically  how  to
           investigate an outbreak and at the end of the one month you  are
           then a qualified epidemiologist in our terms and at the  end  of
           that course I had to go off the  epidemic  intelligence  service
           did to an epidemic. We were constantly being called for  various
           epidemics. There was a big epidemic  of  diphtheria  in  Phoenix
           City, Alabama. I went down, I spent three weeks down  there  and
           giving vaccine, taking cultures. The patients were housed  in  a
           big Red Cross tent. I came back and here was the chief  epidemic
           intelligence service officer packing his bags.  I  said,  "Where
           are you going?" He said, "I have another job. I am going to be a
           state health commissioner." I said, "Well, what  do  I  do?"  He
           said, "I guess you are the Chief EIS officer." I said,  "I  have
           no idea what to do?" He said, "You will learn."

      Sure enough, then I began working in a job that certainly  I  was  not
           qualified for but plunged in. With the mentorship of  this  Alex
           Langmere who was a legendary epidemiologist, a rather  difficult
           person but demanding and  just  a  wonderful  teacher,  just  an
           extraordinary teacher. At the  end  of  two  years  of  this,  I
           finished my duty. I proposed  to  him,  you  know,  we  are  not
           keeping many people on. The people were getting, so many  people
           apply. They are  well  qualified.  All  of  them  wanted  to  do
           academic medicine or pediatrics. Just about nobody wants  public
           health.

      Now, if we offered a 5-year training  program  in  which  you  do  two
           years of training, like a residency in  cardiology  that  I  was
           thinking for myself, and maybe then three years with the  public
           health service. Maybe that would be a  way  to  attract  people,
           then by then you will have, say then, seven years and  we  might
           get people staying longer. Well, he  liked  the  idea  and  then
           well, he submitted it up-line to the surgeon general.  He  liked
           the idea. So, I applied for a five  year  training  program  and
           went back to get my residency.

      At the end of the - well, during the course of the residency, I  found
           this to be frankly rather boring. I was seeing patients and some
           of them had some heart  disease  and  heart  failure,  a  little
           diabetes, a little gastroenteritis. A  little  constipation  and
           sort of the end of the day I felt, you know, if I really  hadn't
           been there, I wonder if it would have made  any  difference  and
           was I making any difference. Am I going to be doing this for  my
           next 40 years?

      Well, meanwhile I had been two  years  in  the  epidemic  intelligence
           service which some exciting outbreaks here and  there  including
           one which was an interesting one in Argentina. There was  a  big
           outbreak  of  food  borne  disease.  They   were   stoning   the
           restaurant, the Argentine government was upset. They thought  it
           was a type of food poisoning due to the  Botulinum  toxin.  They
           wanted our, what we had in the way of antitoxin to  treat  them.
           So I took off for Argentina with such supplies as we had.

Paul O'Grady:    When was this?

D.A. Henderson:  That was 1957. At the end of this I saw  the  secretary  of
           health. He sort of offered "Well, let's go on a hunting trip  or
           a shooting trip with me at my lodge." I said, "You know, I  hear
           you have got an outbreak of smallpox." He said, "Yes."  I  said,
           "I would like to go see it." So he said, "Fine." We took off  on
           an old Pan-Am clipper off the waters and the river on La  Plata.
           On up to another place and we got in a two passenger  piper  cub
           and flew into a smallpox - the area where they had the  smallpox
           and they had an outbreak of smallpox. The people were  in  tents
           in the field and so, about 30 different patients. We  looked  at
           the patients one by one, it was fascinating. And at that  point,
           I had never seen a case of smallpox, really didn't know what  it
           looked like. But it was my first contact with smallpox.

Paul O'Grady:    Was there at  that  point  any  national  or  international
           interest in trying to organize the fight for smallpox?

D.A. Henderson:  The international concerns about smallpox were there  very,
           very strongly  because  all  travelers  were  obliged  to  carry
           certificates indicating  they've  been  successfully  vaccinated
           within the preceding  three  years.  Just  about  every  country
           including our own enforced this. If you weren't  vaccinated  you
           wouldn't get admitted or they might vaccinate you on  the  spot.
           There was a great concern about importations of smallpox.

      It was in 1958, just about a year later after I  had  seen  the  cases
           that the vice-minister of the Soviet Union proposed to the World
           Health Assembly that  they  undertake  a  program  to  eradicate
           smallpox. That was the year the Soviets came back in to  the  UN
           family. They'd withdrawn because of the Korean War and they were
           - they just come back. So the proposal,  they  looked  at  this,
           delegates at the assembly looked at this and they really  wanted
           to be helpful and encouraged the Soviets this time.  So  a  year
           later they approved a program to eradicate smallpox.

      The only thing  was  that  at  -  that  same  time  the  World  Health
           Organization was deeply  involved  in  a  program  to  eradicate
           malaria. And fully a third of all staff were  involved  in  that
           and all the spare money they could get together because  it  was
           very expensive, very costly. The  idea  of  undertaking  another
           eradication program was really not the intent  of  the  director
           general. In fact the only thing he could do is say,  "Fine."  He
           really gave it very little money and a few  countries  then  did
           some vaccinating and tried to get rid of smallpox. They did make
           some progress in this but it basically was going anywhere.  That
           was the beginning. It was 1959 when they decided that they would
           undertake a global program but it really was not  anything  that
           was happening. It was seriously, it was not until 1966 that they
           really took it seriously.

Paul O'Grady:    What was the  attitude  of  the  United  States  government
           towards this program that it seemed to have gotten some  impetus
           from the Soviet Union? Was  there  any  political  peculiarities
           about that?

D.A. Henderson:  There, clearly was an element of Cold War competition.  The
           US was heavily supporting the malaria eradication program,  both
           through  the  organization  very  heavily  and  through   direct
           bilateral donations to the  countries.  So  the  US,  you  could
           almost say, owned the malaria eradication program. The  Russians
           had no program at that point that they could say the same  thing
           about. So, in a way they came in with  this  smallpox  and  said
           look, we got rid of it in the Soviet Union  back  in  the  1930s
           when our vaccine wasn't so good,  when  health  conditions  were
           poor, where personnel were not well trained and we  got  rid  of
           it. So, why can't the rest of the world get rid of it?

      So that's where they came in and then put after 1959,  every  year  at
           the World Health Assembly they would really  give  the  director
           general a very hard time. Why aren't you putting more money into
           the smallpox program? Why do you favor the malaria program?  And
           so that went on as a continuing piece. The  US  really  took  no
           notice of it. It's really what it amounted to  until  really  it
           came up to 1965 when a change came for the US.

Paul O'Grady:    Which was?

D.A. Henderson:  Well, in 1965 - I'll go back  a  little  bit,  1961,  Merck
           Sharp &amp;amp; Dome, at  that  time,  was  introducing  a  new  measles
           vaccine. It caused a lot of fever in children.  So  in  the  US,
           they were using it giving the measles vaccine and they gave them
           some immune globulin at the same time so that they wouldn't have
           so many reactions to the measles vaccine illness, if  you  will.
           This made little practical sense if you went to Africa. The idea
           of  doing  these  two  together  and  made  life  a   lot   more
           complicated. You really could not do large scale vaccination and
           try to preserve the immune globulin and deal with two  shots  to
           get this. So they undertook studies in Upper Volta, Benin. I  am
           sorry Upper Volta  is  the  place  where  they  were  doing  the
           country.

      They did x number of children, 150 -200, kids reacted very well.  They
           were no complications. Then they asked -  the  country  minister
           said, could you give - do it for all kids  under  six  years  of
           age. So they gave them a vaccine enough for that. Then there was
           an organization,  French  organization  that  had  a  number  of
           countries and he said, could we do it  for  six  countries  now.
           USAID said, "Okay, we will  do  it  for  six  countries."  Well,
           things couldn't go very well with six. I won't go  into  all  of
           the complications but we got drawn in at that time to evaluating
           it. I sent one person over to evaluate. It was a disaster.

      Well, not to be deterred they decided  we  are  now  going  to  do  11
           countries. We need from you, 11 people for six  months  each  to
           help get the program started in  each  country.  I  thought,  we
           can't do that. Really, it's - a good segment  of  my  staff  and
           signing people over for  6  months  at  a  stretch  is,  without
           families and what have you, this is tough.  So  I  thought,  you
           know, I really have to work  with  AID,  we  really  got  to  be
           responsive to them. I didn't know what to do. So I decided,  all
           right, let's put together a proposal that we would say is  sound
           from this public health standpoint.

      Why was the measles proposal bad? Well, they were  going  to  give  it
           for just four years and then stop.  In  other  words  AID  would
           support it for four years and they  expected  the  countries  to
           continue. It cost a $1.75 a dose. The countries couldn't  afford
           $0.10 a dose for yellow fever  vaccine.  So  this  is  not  good
           public health practice. To start a program, get the hopes of the
           public up and then drop it. This  is  terrible  way  to  do  it.
           Smallpox had vaccine however, cost  a  penny  a  dose.  So  they
           proposed the idea, well, suppose you take this  whole  block  of
           countries, 18  countries  and  suppose  you  give,  do  smallpox
           vaccination -

Paul O'Grady:    And you talk about West Africa?

D.A. Henderson:  This is west, West and Central Africa as  well  called  it.
           And so we do 18 countries.  You  give  smallpox  and  develop  a
           smallpox program there. We could get rid  of  smallpox  in  that
           whole area, they could then  -  would  have  as  an  established
           program for vaccination. They could continue it easily when that
           only cost them a cent a dose  in  vaccinating  newborns  and  so
           forth. Then if they want to have measles vaccine added  and  the
           ministers think this is a good idea, we would be happy  to  give
           measles vaccine at the same time,  but  we  can't  eradicate  it
           because measles spreads too easily. We couldn't get rid  of  it,
           but at least the countries would have to think through was  this
           a good idea to do this with measles vaccine as well.

      Well, I think the cost - what USAID expected to spend was  about  five
           or $6 million. The proposal we submitted was about $35  million.
           So, I knew it can be turned  down.  But  on  the  other  hand  I
           thought it was going to be a point of departure for  discussion.
           I didn't know where we were going to find any sort of compromise
           on this. They just, their demands were  so  great  that  it  was
           impossible. So I set it up through channels, through the surgeon
           general and very shortly USAID turned  it  down.  We  were  just
           debating along about autumn what we  would  do  subsequently  on
           this.

Paul O'Grady:    And we are still in 1965?

D.A. Henderson:  This is 1965, when all of a sudden we got information  that
           the president had decided to  approve  the  program,  the  whole
           program.  This  shook  everybody.  My  boss  Alex  Langmere  was
           absolutely beside of himself.  As  I  told  him  they  were  not
           supposed to accept it, that was - but the president was  looking
           for an  initiative  which  would  be  something  that  he  could
           publicize that the US was contributing  to  a  UN  International
           Cooperation  Year.  There  were  several  proposals  that   went
           forward. This I had  no  idea  was  even  being  considered  and
           suddenly AID was told by the White House,  fund  it.  All  of  a
           sudden, we are told, all of a sudden we have got 18 programs  to
           set up in the West and  Central  Africa.  We  had  never  run  a
           program outside the United States at all.

Paul O'Grady:    So you guys have been  faced  with  a  tremendous  manpower
           problem?

D.A. Henderson:  Well, we would need about 54 people. That we are  going  to
           have to recruit. AID said that it probably would be - you  can't
           do this under three years. They agreed finally to fund  it  then
           on November. They felt we could get it in three years.  I  said,
           no. This is wrong. It's just got too much of a delay. How  about
           13 months? We will have the people  over  there  in  January  of
           1967.

       They  thought  it  was  almost  impossible.  You've  got   individual
           agreements what  every  country.  You  have  got  to  order  the
           vaccine, you have got to put on training programs, you've got to
           recruit all the people. We did. Recruited the people, we got the
           vaccine ordered. We got vehicles. We  had  to  use  US  American
           vehicles. There weren't  any  in  all  of  these  countries.  No
           maintenance, no repair, so  we  had  to  set  up  workshops  and
           everything else, to train our people to be mechanics. We had  to
           lay out plans for all of the countries to get everything  signed
           and we did.

Paul O'Grady:    Let's talk of, just for a second, about  the  attitudes  of
           the countries  involved.  What  was  the  interaction  with  the
           governments like?

D.A. Henderson:  Well, in November as soon as  this  was  approved,  I  went
           over with a consultant that I had who, Warren  Winkelstein,  who
           was a good epidemiologist and spoke French,  another  person  by
           the name of Dr. Henry Gelfand. The three of us went and  visited
           each of the different countries. Fortunately a  number  of  them
           were having a meeting, so we could present it to all of them  at
           one time.

      They were enthusiastic. Why were they enthusiastic?  More  -  most  of
           them, more because of the measles vaccine because this is a very
           - in Africa, this is a very deadly disease.  It's  10-15%  death
           rate. The French speaking countries by and large had  done  some
           pretty good vaccination with pretty good  vaccine.  The  English
           speaking countries  had  a  lot  of  smallpox.  They  were  more
           enthusiastic about the smallpox. But they were getting both  and
           they were really very  enthusiastic.  We  were  coming  up  with
           vehicles. We were coming up with vaccines  and  consultant  help
           but not a lot of people. It was by and large one or  two  people
           or advisors to be assigned to most of the countries with  a  few
           more in Nigeria.

Paul O'Grady:    And how about the Americans that  were  going  to  go  over
           there as part of this program? Let's talk  a  little  bit  about
           their attitude?

D.A. Henderson:  Well, the Americans who were going over there, a number  of
           the people I - some of them I had known. Basically called up and
           said, we have got this coming up, are you free, or would you  be
           interested, people, contemporaries and so forth. I had a  couple
           of people  who  are  already  serving  in  CDC  and  took  them.
           Basically it was almost word of mouth advertising because  there
           just wasn't very much time, and contact with people  at  schools
           of medicine and other places,  infectious  disease  people  that
           might know of people interested in this. People -  the  word  of
           mouth, by word of mouth they learned about this and my goodness,
           we were able to recruit enough, so that we were  able  to  begin
           the training program in July of 1966.

Paul O'Grady:    And people were on the ground?

D.A. Henderson:  Well, they had to finish up the training.  We  had  to  get
           all the agreements signed. I think we got all of them in  to  16
           of the 18 countries. We managed to put two, postpone two, but we
           had 16 of them by January of 1967. Meanwhile, there is a  little
           problem. There was a debate coming up in the Assembly in May  of
           1966. So this is only like about 6-7 months after this  approval
           for the whole West African program had come through.

Paul O'Grady:    Debate in the United Nations Assembly?

D.A. Henderson:  Debate in the World Health Assembly?

Paul O'Grady:    Okay.

D.A. Henderson:  Every year the ministers  of  health  convene  in  May,  in
           Geneva to look at issues of health. So they  were  debating  the
           question of  going  with  an  intensified  program  of  smallpox
           eradication with  a  budget  of  $2.4  million  a  year  and  an
           objective to complete that within 10 years. The director general
           Marcelino Candau, a very capable  Brazilian  knew  that  it  was
           impossible to  eradicate  it.  He  felt  you  had  to  vaccinate
           everybody in the world and he was a Brazilian and he  knew  that
           there were tribes in the Amazon that hadn't been found. Or  were
           just recently found or  that  sort  of  thing.  So  he  knew  it
           couldn't be done.

      There were a number of  countries  that  were  very  doubtful  of  the
           concept of eradication at all because they were having  so  much
           trouble in malaria eradication. There were  others  who  thought
           this was far too ambitious for an organization  like  WHO  which
           is, where it's not, except for the malaria really it hadn't  run
           programs or really coordinated  that  way  operationally  health
           programs. So it came to a debate in the assembly. The US had, as
           I said, been very quiet before this really in taking a  position
           but at this assembly they were going  to  take  a  vote  finally
           because it was very controversial, whether they  went  ahead  or
           didn't go ahead. One of the strong arguments was well, the US is
           already committed, funds and personnel for - to take care of  18
           countries.

      So that's a big start on this whole thing and after two o three  days,
           three days debate, they did vote. They had  about  58  votes  to
           start the program and it passed by just two votes.  It  was  the
           closest vote they have ever had in the  World  Health  Assembly.
           The director general was furious and felt that the assembly  had
           committed the World Health Organization to a  program  which  is
           going to fail. It would bring the  organization  into  disrepute
           and question the credibility of  public  health  and  the  World
           Health Organization. He blamed the US for this.

      Well, in a way, it was true. If the US had not done this  crazy  thing
           in West and Central Africa  that  almost  certainly  the  voting
           would not have gone as it did. So he was  blaming  the  US.  He,
           then, called the surgeon general in the US and said  I  want  an
           American to run the program because when it goes down,  when  it
           fails, I want it to be seen that there is an American there  and
           the US is really responsible for this dreadful  thing  that  you
           have launched the World Health Organization into and the  person
           I want is Henderson. Well, I was associated, of course, with the
           West African program of having gotten involved with starting  it
           and so forth.

      So I got called to Washington and I was told I was being  assigned  to
           be head of  the  World  Health  Organization's  Global  Smallpox
           Program. I declined. I said, we  are  just  starting  this  West
           African program. We have just - there is a huge amount  of  work
           and we have just barely started. The $2.4 million we got to  go,
           we had programs in 50  countries.  We  don't  even  have  enough
           money, $2.4 million won't even buy the vaccine we need.  Trying,
           I  had  some  experience  in  working  with  the  World   Health
           Organization and they really were  not  working  well  together.
           Each of the six regional offices were sort of wholly independent
           and trying to coordinate them was a terribly job. So I  said,  I
           really can't do it.  I,  you  know,  I  think  this  is  a  very
           difficult task. I really, I think if we do a good  job  in  West
           Africa, we are going to show what can be done. Maybe  that  will
           encourage the other countries but that's, I think, where I ought
           to stay.

Paul O'Grady:    Was this conversation going on between you and the  surgeon
           general?

D.A. Henderson:  Yes. So I declined. He said - I  said,  you  do  not  -  we
           don't order people in the public health service to go from place
           to place. That we - we talk about career opportunities,  and  so
           forth and so on. It's not like the military services.  He  said,
           "Well, this is your career opportunity." I said, "And suppose  I
           decline." He said, "You are fired." I said, "You  are  serious."
           He said, "I am very serious. I will tell you what, make a  deal.
           You go for 18 months and if at any time during  that  18  months
           you really feel it won't go, just send me a telegram,  just  put
           now and I will pull you out." So, I headed for Geneva to head up
           the Global Program.

      We left in October to go to Geneva, get a house. Wife and three  kids,
           plus left half of our household goods in the storage because  we
           knew we would be back pretty soon. Took over  a  program,  which
           was a  global  program.  This  provided  for  headquarter  staff
           eventually of nine of us. It never  got  bigger  than  that.  So
           there were five medical  officers,  two  admin  officers  and  a
           couple of secretaries. That was our total staff.

Paul O'Grady:    Let me ask you about your own mindset at  this  point.  You
           had mentioned the problems with the  measles  program  and  that
           malaria eradication had been problematic. Were you optimistic at
           this point about - at least with respect  to  the  West  African
           piece of the puzzle? You  were  optimistic  about  eradication's
           success?

D.A.  Henderson:   This  is  a  good  question  as  to  whether  you   would
           characterize what I felt is optimistic. My feeling  was  it  was
           doable but without a full appreciation of  everything,  all  the
           problems we would encounter. I must say  because  as  I  thought
           back on it, had I any idea of all the  problems  that  we  would
           face, I would have not been  optimistic.  You  can't  anticipate
           civil wars, floods, masses of refugees, one thing after  another
           and bureaucratic  blockage  of  things,  countries  refusing  to
           participate. All of the difficulties you can have with this, but
           fortunately I was innocent of the problems, these problems  that
           you would encounter or we couldn't anticipate,  obviously,  most
           of these.

      It was the fact we had a good vaccine and the vaccine we knew and  I'd
           worked, we had done some studies at CDC while I was in charge of
           the surveillance program, showing the vaccine was very good. You
           could  get  virtually  a  100  percent  takes,  using  a  proper
           technique. We had jet injectors that  we  had  worked  with  and
           perfected these with the inventor in the  US  Army  so  that  we
           could add jet injectors that could vaccinate a  1000  people  an
           hour. They looked - we looked optimistic that we could do a  lot
           of vaccination with them. So that, we had  a  good  vaccine,  we
           knew something about smallpox. You know  that  -  we  knew  that
           there were a  number  of  countries,  developing  countries  who
           didn't seem to have any cases but the reporting was so bad that,
           little did we know that many of them just weren't reporting it.

      But we just - we really didn't have an idea but we thought there  were
           large countries, free of the disease, certainly the US  was  and
           Canada was. Certainly there must be others  that  were  involved
           too. So it was a feeling of  technically  this  was  doable  but
           without an appreciation that experience would provide as to just
           how difficult the problem would be.

Paul O'Grady:    Let's take you to - take  you  back  to  Geneva.  You  have
           arrived, you had your family there and when  did  you  start  to
           realize that these challenges were going to present themselves?

D.A. Henderson:  We quickly found that we  had  problems.  Within  just  the
           first couple of years, we ran into a number of problems.

Paul O'Grady:    Can you - ?

D.A. Henderson:  The West African program basically,  Don  Millar  who  took
           over from me, who had been my chief of my smallpox unit  before.
           He was running it and he had a good administrative  officer  and
           he had some very good people in the field. My feeling  was  that
           they had to run that themselves and the only thing we could help
           them with, which they needed was some local costs.  I  think  we
           gave them a  couple  of  $100,000  a  year  to  permit  in  some
           countries, purchase a vaccine, gasoline and a few other  things,
           they couldn't get it, legally with their USAID funds. Other than
           that, they were on their own.

      So we worked at the world and saw well,  we  got,  two  countries  are
           sitting rather at the far end. One is Indonesia,  the  other  is
           Brazil. Now at that time, South America appeared to be  free  of
           smallpox except for Brazil. They had done  vaccination  programs
           in the other countries  and  one  way  or  another,  with  their
           infrastructure, not perfect but  they  managed  to  get  rid  of
           smallpox. That of course was encouraging. But if we got  rid  of
           it in Brazil then they would be far away from endemic areas  and
           indeed they could be basically the funds  that  we  are  putting
           into a Brazilian program could be withdrawn and  we  put  it  in
           other areas like Asia or Africa.

      Similarly with Indonesia, Indonesia sitting off where we are here  and
           the countries nearby are free of smallpox.  So  the  chances  of
           smallpox being imported into Indonesia,  if  we  got  that  free
           would be small and therefore the  limited  amount  of  funds  we
           could use have, we could then transfer that to  other  countries
           and at least make a start in trying to get rid of  the  smallpox
           with the limited funds we had. So, that was the strategy.

      We almost immediately found we had a  vaccine  problem.  The  Russians
           had pledged 25 million doses a year and we had no idea how  much
           vaccine we would really need. Most of the countries  were  doing
           some vaccination. The disease was  so  severe,  it  was  such  a
           problem that at least they had to vaccinate in  the  big  cities
           simply because of civil disorder, with too much of this epidemic
           smallpox, it is destabilizing. So in all countries we are  doing
           some vaccination and what we had - we made the  assumption  that
           most of them, already have vaccine and we have  got  25  million
           from the Soviet Union. US is covering all the vaccine  needs  in
           their 18 countries, later 20 countries. So we got to be alright,
           but we - I thought we need to have some way to determine whether
           the vaccine is really, really potent, really good.

      So, I went to the Netherlands and asked if they would  help  in  doing
           testing the vaccine, vaccine quality of the production that  was
           there and then we went to Connaught Laboratories in  Canada  and
           they agreed to do that as well. So we began getting  samples  of
           vaccine from the different countries and they began testing  it.
           Five percent of it was potent and stable. Five percent  met  the
           international standards.

      So we had a problem almost immediately. We couldn't afford to buy  the
           vaccine. So I made a decision, we won't buy any vaccine. We  are
           going to have  to  develop  -  improve  the  vaccine  production
           facilities that are out  there.  We  called  a  meeting  of  the
           vaccine producers from several major  laboratories.  From  Wyeth
           Laboratories in the US, they were the producer  here,  they  had
           one Lister Institute in London, where  Netherlands  were  there,
           Soviet Union were there. I think that was it.  We  brought  them
           together and  we  talked  about  vaccination  and  developing  a
           standard manual. Every country was using where they were  making
           a vaccine they were using all sorts of different techniques.

      So let's get what we think is the best  way  to  do  it  in  a  simple
           manual that I can  understand.  Then  let  us  then  help  these
           countries improve their vaccine. We will, then work with  UNICEF
           to try to get them to provide some machines so that  they  could
           freeze dry the vaccine and we would use some of the people  from
           these consultant laboratories that we had brought together to go
           out and train and help develop the vaccine. That's what we did.

      The vaccine quality began to pickup. It was  by  about  1972,  we  had
           more than 80 percent of the vaccine was being  produced  in  the
           endemic countries themselves and it was good quality. So we were
           immediately  involved  in  trying  to  solve  just  the  vaccine
           problem. How to administer the vaccine was the second problem.

      The problem was this. You have a vaccine which is a very, has a  vial,
           it's in a vial with about 0.25 milliliters  of  fluid.  That  is
           reconstituted. You have one vial that has dried  powder  of  the
           vaccine, another which has a quarter of a  milliliter  of  fluid
           which is a very small amount. To use a vaccine, you have to  put
           the liquid into the dry powder and mix it up. Then  you  had  to
           put it on the arm.  The  way  they  did  this  in  most  of  the
           developing countries was take like a glass rod, dip  it  in  and
           then put it on the - dip the rod against the arm, tip it against
           the arm and a little drop would be there. Then by and large what
           they did was scratch through the vaccine. They had a  number  of
           scratches through the vaccine, it was  an  old  technique  which
           goes back more than a 100 years.

      In the US we did  a  little  bit  differently  but  it  was  the  same
           principle but it was important that the US did it this way. They
           took and took a needle and they put the drop back on the arm and
           then they gently pushed the virus through the skin and the  idea
           was that if you got it just through the skin it  will  grow  and
           produce something. If you push too hard you will  get  bleeding.
           If the bleeding occurs then it washes out the virus.  You  don't
           push hard enough, it doesn't  go  into  the  skin,  and  so  the
           vaccination fails.


      Wyeth laboratories was developing a new device which I  visited  Wyeth
           laboratories because  it  was  the  question  of  improving  our
           vaccine production capabilities in the other countries and  they
           showed me this wonderful device which they developed.  A  little
           needle about - well, tube about so long. There  are  two  little
           prongs on the end. They called it a bifurcated or  sort  of  two
           fork needle. The idea was you put the needle  into  the  vaccine
           and you just withdrew it. Between those two  prong,  the  little
           bit of vaccine would be held and then they thought you press  it
           through the skin.

      In this way the amount of vaccine you could get from a  vial  was  100
           doses rather than 25 doses. Well, I looked at it and I know  how
           much trouble we had had in  trying  to  teach  them  to  medical
           students how to vaccinate because they were forever not  getting
           it quite - not enough pressure to break the skin. So  it  wasn't
           growing and then a number of them are getting a  little  bit  of
           drop of blood and that was thought to be bad. So  I  raised  the
           question of well, suppose that we take a needle and just hold it
           like this and poke it like this, we called it multiple puncture.
           Instead of  scratching  or  pressing  it  through,  do  multiple
           puncture. You are going to  get  bleeding.  So  let's  see  what
           happens.

      So we tried a few of these, they all got  very  successful  takes.  We
           took it to the field into Kenya and Egypt and  did  several  100
           children and we did it very vigorously. There was a little  drop
           of blood on everyone. Every single one of them  was  successful.
           So this was incredible. All of a sudden we were  going  to  have
           four times as much vaccine than we thought  we  had  or  we  are
           getting, with these wonderful needles. The needles cost  us,  we
           shortened them up a little bit and make  them  cheaper  than  we
           made them out of a stainless steel virtually.  We  could  get  a
           thousand of them for $5. You could boil them and reuse them  and
           we ran through about a 120 vaccinations perfectly  good.  So  we
           had needles very inexpensively.

      We had a vaccine and suddenly we had four times as much vaccine as  we
           thought we had. Then it was a matter of bringing those into play
           in the different countries and this went very rapidly. So it was
           another development, right at the beginning which  made  a  huge
           difference. It was a  crazy  little  thing.  Now  the  important
           thing, I think was is that the - the inventor of this, a man  by
           the name of Ben Rubin received a one time, to tell  you,  what's
           called the John Scott Medal of the City of Philadelphia for  the
           best, most important invention of a particular year. Here he was
           getting this and it had gone back - the award goes back  to  the
           1700s. Marconi has received it, Edison has received it so forth.
           He said, "This is the most insignificant patent or  invention  I
           have ever made," and he said, "And here I am receiving the  John
           Scott medal." And it was - it just was like inventing the safety
           pin. It was so incredible.

      So we began using that, we had - introduced the jet injector for  West
           Africa but very soon we said,  for  this  price  we  don't  have
           problems in mechanic to repair  or  what  have  you.  It's  very
           inexpensive, much less expensive than a bio - than jet injector.
           So pretty soon the bifurcated needles took over the whole of the
           world in terms of vaccination. Well, we had a couple of the very
           early problems that we had. There were many more.

Paul O'Grady:    So tell me how the smallpox program  moved  into  Asia  and
           East Africa?

D.A. Henderson:  Well, West Africa, I want to go back to  the  West  African
           program which began in '67 and they managed to record their last
           case in 1971. Well, ahead of schedule and under budget. Not  too
           many programs come through like that. Meanwhile, I had a man  in
           East Africa and he was working with the people in the  different
           countries and helping them  and  strengthening  what  they  were
           doing, a Russian, Ivan Ladnyi and they began to make  very  good
           progress. We, from WHO, began  supporting  Central  Africa,  not
           Central Africa, but Sudan  and  Zaire  are  two  huge  countries
           across the middle. This was frightfully  difficult  but  we  had
           some very good people, incredible people.  Some  national,  some
           internationals and they began to make a good deal of progress.

      Brazil, I got  back  to  say  Brazil  became  free  in  '71.  We  had,
           Indonesia was a bit of struggle but they became free by 1972. In
           fact the whole of  Africa,  was  free  of  smallpox  except  for
           Ethiopia. The whole of Africa was free of smallpox by the summer
           of 1973. We were only six years into the  program  and  here  we
           were with a good piece of the world free now of smallpox. So, in
           the summer of 1973, we were down to - just five  countries  that
           had  smallpox,  just  five.  It  was  India,  Pakistan,   Nepal,
           Bangladesh in Asia and Ethiopia.

      When you looked at India and that group - that bunch of  countries,  I
           think the population then was maybe about 700  million.  So  you
           look at it and you say, only four  countries  in  Asia  but  700
           million people is, at that time, almost three times the size  of
           United States. So it was not a small undertaking  to  deal  with
           that. Meanwhile in Ethiopia, they were doing a malaria  program.
           They did not want to see a smallpox program. So, the Minister of
           Health refused to even have  me  go  and  talk  with  him  about
           starting a program. So nothing had happened in Ethiopia  at  all
           on smallpox, up until late 1970 before I  managed  to  get  into
           Ethiopia and lay out a  plan  and  by  various  devices  working
           through the emperor to get approval to get started in Ethiopia.

      So we came in the summer of '73. We had programs in all the  countries
           and we were very optimistic that now we are on our way. The  big
           problem, frankly, at that time was India. Huge country, a number
           of people talked about India being like the native, like we talk
           about cholera being the home or India being the home of cholera.
           There are some who said, well, India with very dense population,
           particular climate  and  so  forth.  They  must  have  something
           special  here  that  maybe  is  the  home  for  smallpox.   Very
           difficult, you will never get rid of  it  there.  That  was  the
           general discussion that was going on.  We  weren't  making  much
           progress.

      India had started a program back in 1962, not so long after the  first
           World Health Assembly heads said, well, let's do an  eradication
           program. By the time they got to 1973  it  really,  they'd  made
           progress some of the southern states of India but most of India,
           they were still recording as much smallpox  as  they've  had  11
           years before. They were discouraged and really,  not  sure  they
           would continue. There was a lot of discussion about it. It was a
           problem saying we really have to keep going. They agreed  to  do
           so and this was the earlier 70s. They agreed to  keep  on  going
           but then we met and sort of the late spring of '73 and we  said,
           we have got to do something different.

Paul O'Grady:    Who's meeting?

D.A. Henderson:  In India, well  the  strategy  that  we  had  had  was  not
           working. They had done a lot of  vaccinating.  They  were  doing
           mass vaccination all the time, they were then  beginning  to  do
           what we called surveillance and containment. Really getting much
           better reporting and when a report came  from  a  village,  they
           would go out, send a team out. Try to vaccinate and control  the
           outbreak. It didn't seem to be working and there was a  still  a
           lot of cases and we were - they were  not  making  progress.  So
           that spring we decided what we needed to do was find  the  cases
           more quickly. Find them before they became outbreaks.

      So the decision was made  that  we  try  to  undertake  a  village  by
           village search throughout the whole of India in  10  days  time.
           Mobilize the health services for an  intensive  10  day  search.
           With this we were - would employ about a 120,000 people. And the
           idea initially was to go to selected parts of the village  in  a
           particular pattern to try and find cases and see what you  could
           turn up. There was a lot of planning. A lot of organization went
           on. We got Bill Foege from CDC, was sent over. I had  asked  for
           more help. They sent over a couple of people but India is a  big
           place and we have a very  cracked  team  of  international  from
           France, from Czechoslovakia, from Soviet Union, but not  a  lot,
           we were very few.

      So the first search was completed in October  in  this  one  state  of
           India. We were normally getting about 500  cases  a  week.  That
           first search was completed and they  recorded  10000  new  cases
           found, 10000 new cases. This wasn't even the high point  of  the
           season. This was really at the - almost the  beginning  of  when
           the seasonal increase occurred. Oh my gosh!  This  is  far,  far
           worse than we had ever imagined. Well, it was  even  worse  than
           that, because it wasn't several weeks later  I  found  that  the
           search teams had not done a great job and  they  really  reached
           only half of the villages. So it was probably twice  as  bad  as
           bad as I thought it was.

      They repeated the search in another two months and  they  got  better.
           By about the third search they got into  the  point  where  they
           would do house to house. We actually had a  team  following  and
           doing a sample number of the villages to make sure that they had
           really reached at least 80 percent of the houses.  So  we  began
           gradually to mobilize this tremendous force. It took 8  tons  of
           paper for one search. We began getting  more  cases.  The  cases
           were increasing. The problems were that of mobilizing the staff,
           of supervision, quality control. It was a really tough  job.  We
           went on and through the summer of 1974, when at  that  time  the
           smallpox goes down to its low as  points.  Some  of  -  smallpox
           transmits best like measles in the winter. Measles is  a  winter
           disease, smallpox is the same.

      Whatever it is, whether it's being dryer air and cooler air that  does
           it we don't really know  all  the  answers.  But  certainly  the
           summer months are where it gets to  the  lowest  point.  So  the
           summers and the states, northern states where  this  almost  all
           the smallpox was, the summers are terrible, 120  degrees.  There
           is not - limited amount of electricity and there is certainly no
           air conditioning. We were bringing in a lot of people who are on
           3-month volunteer stints  with  their  Indian  colleagues.  That
           summer it was murder. We brought them together,  once  a  month,
           looked at what they had done. Reports, we viewed all  of  these.
           We had no cell phones, we  had  no  telephones.  There  were  no
           computers. I mean, this was all done by hand. They'd come in for
           a weekend. We'd come in for work for a day and then they had one
           day of rest.

Paul O'Grady:    Can you identify a turning point in the Indian experience?

D.A. Henderson:  Yeah, I will come to that.  At  the  moment,  there  was  a
           turning point but a strange one. We worked through  '74  but  we
           got started going into late '74. The seasonal  pick  up,  picked
           up. There were more cases than ever, it was really a  going  and
           there were several longer term trends in the  disease  in  India
           and this was a little [1:03:18 inaudible]  with  a  longer  term
           trend. It was on its way up and we were not having that much  of
           an effect.

      However, by the time we got to around February, we realized  that  the
           search system was in place. That we had some  very  good  people
           supervising this and in fact I even remember  the  time  it  was
           with, Bill Foege, the  two  of  us  were  looking  at  this  and
           wondering now, where were we at this point in time  and  that  -
           but as Bill said, I am not sure I am going to put out a weekly -
           putting out, I guess a bi-weekly report and the curve was  going
           up and he said, the only thing I can  do  that's  optimistic  is
           turn it upside down. But we felt at that time, secretly that  we
           are on our way and they got worse.

      It got worse for the bad time in a way and  a  good  time  in  others.
           India detonated a nuclear device. They had people, press  coming
           from all over. The theme of all of the coverage,  news  coverage
           was India detonates nuclear  device,  smallpox  -  their  health
           system is so bad that they are the world's primary  country  for
           smallpox. So here is this advanced country with  such  primitive
           health facilities that it's epidemic for smallpox.  This  got  a
           lot of interest. The Indian government  was  not  pleased.  They
           were very upset and they began making more resources  available.
           Higher levels in government began paying  attention  to  it  and
           they assigned to the program, from  the  Indian  side,  four  of
           their very best people to work with four of our central  people.
           We call it the central appraisal team.

      Well, we got over that and for India at least, when  we  came  to  the
           end of the last cases in May of 1975, we thought we had the last
           case. There was a beggar woman out on a railway platform in  the
           far eastern part of India going into a whole area  and  she  had
           infected a bunch of people going after. We had no idea what  was
           going on.

      By that time  by  October,  the  Minister  of  Health  and  the  Prime
           Minister were very excited about this.  We  were  not  confident
           that we got rid of smallpox. October 5 - August 15th is  India's
           Independence Day. They were determined to announce that this was
           India's Independence Day and it's freedom from smallpox for  its
           first time in history. I would say we were chewing nails at that
           time, thinking, oh my gosh! If they have more cases,  you  know,
           the press coverage and these people don't  know  what  they  are
           doing, oh god. It would have been awful, that was the last case.

      Meanwhile, Bangladesh was  going  through  tragedy  after  tragedy  of
           flood and famine  and  we  had  an  exhausted  group  of  really
           fighting to get rid of it in Bangladesh which is  a  story  unto
           itself. So, on August 15th, the Director General and  I,  headed
           for Bangladesh. They only had I don't know, something like maybe
           80 villages infected at that point. It was  just  really  coming
           way down and we felt, my gosh! I think we are going to have - be
           rid of this bad disease for all the world. It was a very  severe
           time for smallpox. That would have been in.

      So we are on our way to the airport and got the word, all flights  are
           canceled. The President of the country, the really the  founding
           father of the country, Mujibur  Rahman,  had  been  assassinated
           along with his entire family. Martial  law  had  been  declared.
           Troops were moving  to  the  border.  Floods  of  refugees  were
           expected. We thought, oh my god, once more, but for some reason,
           the international group, was laid low. They worked locally, they
           kept out of the way and the expected civil war that was expected
           to erupt immediately did not. They went back to work and finally
           in October of '75 it was all done in Asia.

      Then we were left with Ethiopia  and  Somalia,  subsequently  Somalia.
           Well, if you like to hear the rest of the  story  I  can  go  on
           Ethiopia but Ethiopia is a huge country. People look at the  map
           and they say oh, it's about the same size as  Georgia,  but  not
           so. It's equivalent to all of the states on the eastern seaboard
           of the United States in area. It's  huge.  There  are  very  few
           roads or where there are roads or even roads you can  drive  on.
           It's estimated I think that, two-thirds of the population  lived
           more than one day's walk from any accessible road, at least  one
           day.

      We had just - the government had only, I think,  2000  health  workers
           in the whole country. For  a  while  we  were  working  with  20
           Ethiopian sanitarians, 14 US peace  corps,  about  six  Japanese
           peace corps and some Austrian peace corps  and  some  volunteers
           who kind of wandered in. Anybody who wanted to work, we put them
           to work and paid them the Ethiopian per diem which if you didn't
           [1:09:59 inaudible] high on the hog on that one, I can tell you.
           Then as they were making progress, slowly but it was  difficult.
           Some of the - first time we ran  into  a  huge  area  where  the
           people fought against vaccination. They didn't want it.

      Trying to solve that problem, took us  some  doing  but  finally  they
           wanted malaria drugs and we could give them  malaria  drugs.  We
           got malaria drugs to give them,  provided  they  got  vaccinated
           first. So they got vaccinated first and then got the drugs.  Not
           the way you like to run a program but that was the only  way  we
           were going to stop the disease. It was a  less  severe  decision
           than let's say in  Asia.  So  there  is  less  motivation,  less
           concern on the part of government.

      Well, we got all of a sudden the emperor Haile Selassie was in  charge
           and had been there you know, as emperor for a  long  time.  They
           had a coup, military coup. Marxist  military  group  took  over.
           Civil war broke out, so there was fighting in different parts of
           the country. The emperor was, I don't really know what  happened
           to him. I think he was killed. Then it was the  US  Peace  Corps
           had to pull out as did the other groups. A number of the embassy
           people pulled out and for a quite a  period  of  time  the  only
           people allowed by the military to go outside of Addis Ababa were
           the smallpox group.

      We had some pretty very good people, particularly our person  who  was
           the real leader of the program, he was a Brazilian fellow by the
           name of Ciro de Quadros. He  had  a  charm  and  an  ability  to
           persuade that was legendary. That's why we had permission to  go
           outside the country but that wasn't much fun because they were -
           we had to go to many  of  the  provinces  with  military  escort
           because it was too dangerous. So  they  fought  through  all  of
           that. It was really horrendous and then they came to a point.

      Finally we got additional people in,  and  then  finally  the  surgeon
           general of the United States came up with a  contribution  of  a
           million dollars for us to get  three  helicopters  to  transport
           people. It was so big. That made a huge difference. Well, one of
           them was shot down, one of them getting up there - I don't know,
           we don't know what reason went into like Kenya. Another one  was
           hit with - they threw a hand grenade at it. They were a pair  of
           those, of those and they took one for the - we had to get at one
           of them with a hostage and they were captured and we had  ransom
           notes which I've still got a copy of the request for ransom from
           the people dictated by the rebels,  written  by  the  helicopter
           pilot. While he was captured took the vaccine and  got  all  the
           rebels vaccinated, so took care of that, he was thinking all the
           time.

      Finally we got to this place in Dimo, a little  village  way  down  in
           the desert, last  case.  I  flew  down.  We  thought  we  got  a
           television crew down there, film this and we did and got  a  lot
           of footage of Dimo, crazy little village sitting in  the  middle
           of a desert. We had a hard time even finding it with  the  -  by
           helicopter, you couldn't spot at great distance.  We  went  back
           and we waited and they searched. Nothing, nothing.  It  went  on
           for eight weeks. We were about ready to make a statement at  the
           press, we are done. There was a report came in of two  cases  in
           Somalia right next door.

      Well to make a long story short, the Somali government, even  for  the
           all the discussions we had had with them, had been hiding cases.
           They knew they had smallpox.  They  were  admitting  them  to  a
           hospital in a sort of secret ward, nobody knew about. They  were
           trying to stop it but because they were  embarrassed,  the  only
           country with smallpox. They hated the Ethiopians and they  hated
           the thought that Ethiopia was free of smallpox. They refused  to
           believe that they were free.

      This went on and as they would let our people come in but  they  would
           let them go out beyond the main city  of  Mogadishu.  The  cases
           kept occurring but they are having  trouble  finding  out  where
           were they coming from, in other words, who was  infecting  them.
           Finally, there was a great discussion  about  this  and  one  of
           them, the turning points, I  think  it  was  that  a  couple  of
           turning points had happened. One being  they  captured  a  Dutch
           adviser who we had working with Ethiopians. He was kidnapped, if
           you will, with his team and vehicle and taken  to  Mogadishu.  I
           think we had eight or nine of these and then the UN commissioner
           would intervene and talk to president and minister.

      This fellow Bert van Ramshorst, finally they took him. He has  to  see
           the minister. So he spent, sat down with the minister and pretty
           well, persuaded him that Ethiopia was free of smallpox and  that
           there was a problem and that the - WHO would be willing to  help
           and so forth and so on. He made a quite a persuasive pitch here.
           Meanwhile, Assistant Director General, Ivon Lodney indicated  he
           would want to come down and visit the city of Mogadishu  at  the
           capital and meet with the Minister.  The  Director  General  was
           threatening to do the same and I think the pressure was on.

      Then they began to loosen up. So from then until this was about  March
           of '77 and the number of cases, I recall are  about  3000  cases
           finally that they had troubles because  they  had  nomad  groups
           moving all over the desert area, couldn't  find  them.  Smallpox
           kept spreading and you couldn't vaccinate them. It  wasn't  that
           they would resist vaccination, you couldn't find them. Then  the
           great problem was, come November, was the Hajj. Somalia is right
           near Saudi Arabia. Many people come from Somalia to  Mecca.  All
           we could imagine were people and they would  come  from  through
           Somalia from other countries, all we could imagine  was  can  we
           possibly have at this time, one of these groups  infected  going
           into Mecca and spreading  it  among  hundreds  of  thousands  of
           people and watching smallpox go like this.

      So there was a frantic effort in terms of - they flew in vehicles,  so
           we had more mobility and flew in all sorts  of  people  and  the
           government declared a national emergency and it went all out. On
           October 26, 1977, Ali Maow Maalin, a cook  23-year-old  was  the
           last case of smallpox. That was the end of the smallpox. We  had
           to spend two more years working in the countries to make sure it
           was really the last one.

Paul O'Grady:    How  did  you  find  out  about  that  last  case,  do  you
           remember?

D.A. Henderson:  Oh, yeah. They had brought in some people at this point  in
           time. They were moving people to an isolation camp to make  sure
           that they would be held. There was two kids who were brought  in
           by a vehicle from outside one of the program vehicles  and  they
           brought them in and they stopped  at  the  hospital  to  inquire
           about where the camp was. Ali Maalin was a cook at the hospital.
           He was supposed to have been vaccinated but he  wasn't.  He  had
           been a vaccinator, in fact but he hadn't been vaccinated. How we
           went wrong, - he got in the vehicle, rode for about  10  minutes
           till they got to the isolation camp. He got out and he came down
           with smallpox.

      Well, he came down with a rash, and as often the case the last is  the
           worst. He was admitted in a hospital and  diagnosed  as  chicken
           pox. Finally, they had  discharged  him  with  a  mild  case  of
           chicken pox and it was one of the other people, friends of  his,
           who said,  I  don't  think  this  is  chicken  pox.  It  wasn't,
           smallpox. He was a very popular guy and he had contact with  all
           sorts of people. So, there were everything  from  roadblocks  to
           all night searches throughout Mogadishu to goodness knows  what,
           trying to find possible other cases, but it was the last.

Paul O'Grady:    So do you have any final thoughts,  anything  you  want  to
           share about your experience with over the course of the years in
           the program?

D.A. Henderson:  Well, I think there were several things about  the  program
           that were very special and that is that we came together, people
           from across the world worked together very well. I  worked  very
           closely with the Russians. It was during the darkest days of the
           Cold War. Totally cooperative, we shared all  sort  of  problems
           and they had some things that needed to be corrected and I  flew
           to Moscow. We talked it over, they corrected them. We had people
           working across borders from one country to another. We  had  mix
           of nationalities out there. What was perfectly clear was that if
           we had a goal, we had leadership at all  these  levels  that  it
           became a very unique situation. Bridges were built such  as  you
           can't imagine. It formed the basis for going  on  from  smallpox
           and we really convened a meeting  and  before  the  program  was
           over, to say, the vaccination has been so  inexpensive.  We  can
           vaccinate  so  many  people  in  a  day,   so   effectively   so
           efficiently. We should be doing more of the smallpox vaccine.

      This  was  an  international  meeting  we  held  and  from  that  came
           recommendations for an expanded program for immunization,  which
           was finally accepted by the World Health Assembly in 1974,  even
           before the end of smallpox. The idea was to add other  vaccines,
           diphtheria, whooping cough, tetanus, the  DPT  vaccine,  measles
           and polio and add this to smallpox. That was  adopted  and  then
           UNICEF got behind it and rotary got behind the  polio  side  and
           the goal was at that time to reach 80  percent  of  the  world's
           children by 1990 with these six vaccines. At the  beginning,  we
           estimated that at best about 10  percent  were  receiving  these
           vaccines. So we had cases of  tetanus  and  diphtheria.  Totally
           preventable diseases, whole wards full of whooping cough and  so
           forth and good vaccines out there, well, made it. So by 1990, 80
           percent of the world's  children  had  been  vaccinated  against
           these  six  diseases.  So  this  was  the  expanded  program  in
           immunization which  is  going  on,  became  in  due  course  the
           eradication of polio. It served to eradicate measles  throughout
           the western hemisphere. Measles was gone.

      We had so few cases of tetanus and diphtheria that it was  a  amazing,
           they were  exceptionally,  just  throughout  the  whole  of  the
           Americas, they developed reporting system which I think, at  the
           beginning we had 500 hospitals reporting once a month. The  last
           count I looked at the reporting, they had weekly reporting  from
           42000  sites  in  Latin  America.  People  just  -  it's  better
           reporting for these diseases than it is in the United States  of
           America. This is going on to develop the group that has convened
           here, have done all sorts of marvelous things and  out  of  this
           came a feeling  of  we've  done  this,  why  can't  we  take  on
           something else. They have done that with great success.

      So, if there is a real need for  an  international  organization  WHO,
           even though there is some of those like our President  Bush  who
           have not felt the need to work with other countries, this  could
           never have been done in the United States, it could  never  have
           done by a  few  countries,  it  had  to  have  an  international
           organization. It showed also how much you  can  do  if  we  have
           preventive medicine and public health vaccines. We were  dealing
           with 10 to 15 million cases of smallpox a year, 2 million deaths
           a year and 10 years later we have zero cases, and  zero  deaths.
           This is pretty dramatic.

      Now you  are  seeing  similar  things  happening  with  measles.  Very
           dramatic changes and now we are talking  about  with  the  Gates
           Foundation supporting a lot of  things,  why  can't  we  go  and
           tackle malaria in a different way. Why aren't we doing  research
           to get better vaccine for tuberculosis,  why  don't  we  have  a
           vaccine against malaria? It's opened  up,  it's  begun  a  whole
           revolution in prevention which is really something to see. Today
           or last couple of days, we have been hearing  reports  of,  now,
           how many different fronts it's moving on very rapidly and really
           rethinking all of this.

      It has, I think, built bridges in the  international  field  that  you
           can't build in agriculture or education.  Those  are  political.
           Agriculture, for obvious reasons,  even  education,  it  becomes
           quite political. With the health side, you really just don't get
           into political issues. It's amazing, you don't and thus  it  has
           built relationships in ways that are really quite unique  across
           the Americas which I have spent more time with  recently.  There
           have been in other areas as well. They had days  of  tranquility
           in the  Americas,  where  in  the  fighting  in  Nicaragua.  The
           agreement was they would stop fighting for  two  days  and  they
           would and the vaccination team to go out. This has  happened  in
           Afghanistan, days of tranquility. So that even the rebel  groups
           could be approached and could be helpful.

      So we got to Peru in the end of polio in the Americas, the last  cases
           were in the area called the Shining Path, where the Shining Path
           was. They destroyed hospitals, they destroyed schools what  have
           you. What the people really behind the scenes, Ciro  de  Quadros
           who was the head of immunization for the Americas had  met  with
           the commanders of the Shining Path and talked it through and got
           commitments from them, not to harm  the  health  workers.  Well,
           they went through and this is what the health workers are doing.
           Guess  what,  they  searched  this  whole  area  which  was   so
           dangerous, it was a problem for the military to go into.

      So there, it's something that I think is unique about health here  and
           something which gives you great encouragement  for  the  future.
           Thus, I really feel  quite,  I  feel  like  we  have  a  made  a
           difference well  beyond  smallpox  eradication.  I  think,  well
           smallpox eradication, I think has been the first  step.  We  are
           now moving on well beyond that into many more exciting things.

Paul  O'Grady:     Great.  DA  Henderson,  thank  you  very  much  for  this
           interview.

D.A. Henderson:  Yeah, you are very welcome.

[End of audio 1:29:16]
&lt;/pre&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="86">
          <name>Player</name>
          <description>html for embedded player to stream video content</description>
          <elementTextContainer>
            <elementText elementTextId="65093">
              <text>&lt;iframe width="560" height="315" src="https://www.youtube.com/embed/qbfMSB8kwAs" frameborder="0" allowfullscreen="allowfullscreen"&gt;&lt;/iframe&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="43076">
                <text>interviews</text>
              </elementText>
              <elementText elementTextId="43077">
                <text>motion pictures</text>
              </elementText>
              <elementText elementTextId="43078">
                <text>moving image</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="43079">
                <text>2008-07-12</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="43080">
                <text>http://pid.emory.edu/ark:/25593/16rdc</text>
              </elementText>
              <elementText elementTextId="43081">
                <text>emory:16rdc</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="43082">
                <text>19266000000 bytes</text>
              </elementText>
              <elementText elementTextId="43083">
                <text>video/x-dv</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="43084">
                <text>O'Grady, Paul (Interviewer)</text>
              </elementText>
              <elementText elementTextId="43085">
                <text>Henderson, Donald (Interviewee)</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="43086">
                <text>Centers for Disease Control</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="43087">
                <text>HENDERSON, D. A.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="43088">
                <text>Donald Ainslie Henderson, MD, MPH, was seconded by Centers for Disease Control and Prevention to the World Health Organization in 1966 and served as the Director of the Smallpox Eradication Program until 1977. </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="43089">
                <text>Smallpox Eradication</text>
              </elementText>
              <elementText elementTextId="43090">
                <text>Smallpox Eradication</text>
              </elementText>
              <elementText elementTextId="43091">
                <text>WHO</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="43092">
                <text>English</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
  <item itemId="5329" public="1" featured="0">
    <fileContainer>
      <file fileId="2949" order="1">
        <src>https://www.globalhealthchronicles.org/files/original/cb7475e7a333797eee0784fa07df81a1.jpg</src>
        <authentication>6b06d68571895aea924311292d8aaa65</authentication>
        <elementSetContainer>
          <elementSet elementSetId="5">
            <name>Omeka Image File</name>
            <description>The metadata element set that was included in the `files_images` table in previous versions of Omeka. These elements are common to all image files.</description>
            <elementContainer>
              <element elementId="74">
                <name>Bit Depth</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="58405">
                    <text>8</text>
                  </elementText>
                </elementTextContainer>
              </element>
              <element elementId="75">
                <name>Channels</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="58406">
                    <text>3</text>
                  </elementText>
                </elementTextContainer>
              </element>
              <element elementId="73">
                <name>Height</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="58409">
                    <text>386</text>
                  </elementText>
                </elementTextContainer>
              </element>
              <element elementId="72">
                <name>Width</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="58410">
                    <text>300</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
      <file fileId="2883" order="2">
        <src>https://www.globalhealthchronicles.org/files/original/f80aca498bb46502cb0bc096b7ee57ec.pdf</src>
        <authentication>a468e39de2d04039f2903843eb74dacf</authentication>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64882">
                  <text>Malaria Control: CDC Beginnings</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64883">
                  <text>&lt;div class="landing"&gt;
&lt;p&gt;In 1942, when the U.S. was mobilizing for the Second World War, the U. S. Public Health Service set up a program to protect the personnel of military bases in the Southeastern states from malaria. This disease had long been rampant in the area, and posed serious threats to the health of the military and civilian populations. The program known as Malaria Control in War Areas (MCWA) was created to carry out the work. The lack of space in Washington due to the war effort allowed the program to base its headquarters in Atlanta, Georgia, and closer to the work at hand. During the war years, the program was expanded to include the control of other communicable diseases. Because its work was so successful, a new organization was created around the nucleus of MCWA, the Communicable Disease Center (CDC). The date was July 1, 1946. This archive chronicles the agency’s early history from 1941-1951, including the contributions of local businessmen and Emory University. The buttons to the right will connect you to a searchable database of documents, oral histories, photographs and media. To conduct an advanced search, use the link in the blue navigation bar above. Use of this information is free, but please see &lt;strong&gt;“About this Site”&lt;/strong&gt; for guidance on how to acknowledge the sources of the information used.&lt;/p&gt;
&lt;/div&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="17">
      <name>Moving Image</name>
      <description>A series of visual representations imparting an impression of motion when shown in succession. Examples include animations, movies, television programs, videos, zoetropes, or visual output from a simulation.</description>
      <elementContainer>
        <element elementId="11">
          <name>Duration</name>
          <description>Length of time involved (seconds, minutes, hours, days, class periods, etc.)</description>
          <elementTextContainer>
            <elementText elementTextId="56991">
              <text>1:55:20</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="86">
          <name>Player</name>
          <description>html for embedded player to stream video content</description>
          <elementTextContainer>
            <elementText elementTextId="65214">
              <text>&lt;div style="padding:100% 0 0 0;width:100%;"&gt;&lt;iframe style="width:100%;height:1500px;" src="https://globalhealthchronicles.aviaryplatform.com/collections/2843/collection_resources/132665?embed=true" frameborder="0"&gt;&lt;/iframe&gt;&lt;/div&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="58663">
                <text>HENDERSON, DONALD "D.A." &#13;
</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="58664">
                <text>Dr. D.A. Henderson, EIS Class of 1955 describes his roles in the early days of CDC and his relationship with Alex Langmuir.&#13;
&#13;
Interviewed by Karen Torghele</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="58665">
                <text>The David J. Sencer CDC Museum at the U. S. Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333&#13;
www.cdc.gov/museum&#13;
</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="58666">
                <text>April 12, 2012</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="58667">
                <text>HendersonDA(After combining)(1).mp3</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
  <item itemId="3506" public="1" featured="0">
    <fileContainer>
      <file fileId="3341" order="1">
        <src>https://www.globalhealthchronicles.org/files/original/856ae8e9debcf0a0fb88fad7eec1217f.jpg</src>
        <authentication>c4496bf89f802d44f19921c5977ef646</authentication>
      </file>
      <file fileId="1487" order="2">
        <src>https://www.globalhealthchronicles.org/files/original/84ddaacdfd3a2e0353d387af7eea8d34.mp3</src>
        <authentication>3ace9d384155207cd1d834f6b9c8e3ea</authentication>
      </file>
      <file fileId="5941">
        <src>https://www.globalhealthchronicles.org/files/original/62c38e3955439f427d51ca7b3a2385ff.pdf</src>
        <authentication>1279ef2ab906908d12145d08f49aad64</authentication>
      </file>
    </fileContainer>
    <collection collectionId="1">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64878">
                  <text>Smallpox</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64879">
                  <text>&lt;div class="landing"&gt;
&lt;p&gt;Smallpox disease was declared eradicated in 1980, the result of a collaborative global campaign. To date, it is the only disease affecting humans to be eradicated from the world. Global eradication of smallpox ranks among the great achievements of humankind. Gone, through determined human effort, is a disease which has brought death to millions, frequently altering the course of history, and traveling through the centuries to every part of the world.  &lt;/p&gt;
&lt;p&gt;The vital contributions made by the Centers for Disease Control and Prevention are highlighted. Official government correspondence, meeting transcripts, policy statements, surveillance reports and mortality statistics tell a part of that story. Adding depth to these traditional archives are the personal stories of the public health pioneers who worked tirelessly on the frontlines of the smallpox eradication campaign.&lt;/p&gt;
&lt;p&gt;The links above connect you to a database of oral histories, photographs, documents, and other media.&lt;/p&gt;
&lt;p&gt;Use of this information is free, but please see &lt;strong&gt;“About this Site”&lt;/strong&gt; for guidance on how to acknowledge the sources of the information used&lt;/p&gt;
&lt;/div&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="17">
      <name>Moving Image</name>
      <description>A series of visual representations imparting an impression of motion when shown in succession. Examples include animations, movies, television programs, videos, zoetropes, or visual output from a simulation.</description>
      <elementContainer>
        <element elementId="5">
          <name>Transcription</name>
          <description>Any written text transcribed from a sound.</description>
          <elementTextContainer>
            <elementText elementTextId="42565">
              <text>&lt;pre&gt;&lt;strong&gt;
 Interview Transcript
&lt;/strong&gt;
This is an interview with Ilze Henderson on July 13, 2006, at the Centers
for Disease Control and Prevention in Atlanta, Georgia, about her
involvement with the West African Smallpox Eradication Project. The
interview is being conducted as part of a reunion marking the 40th
anniversary of the launch of the program. The interviewer is Alicia Decker.


Decker:     What I thought would be an interesting way to begin is for you
           to just briefly describe your early life, some of the major
           factors or influences that affected you as you were growing up.
Henderson:  That's a question that's hard for me to answer. I was born in
           Riga, Latvia, and my life was very normal until age 7. Then the
           world fell apart. Now we call it genetic cleansing. It was
           Soviets shipping out people to Siberia. They just missed my
           family, so we had to flee to my grandparents, to the country.
           But that was the first time I realized that you can't depend on
           anyone. Then the war started. Finally, we fled to Germany and we
           stayed there, in southern Germany, until the war ended, and then
           spent 5 years in displaced persons camps.
                 We came to the United States. Immigrants are sponsored.
           Well, our sponsor had become a drug addict, and he was losing
           his own job. So we managed. Finally, my father got a job in
           Milledgeville State Hospital, the largest hospital in Georgia,
           if not anywhere else, and,despite being a surgeon, he became a
           psychiatrist.
                 Then I went to the University of Georgia, degree in
           pharmacy, and worked here in 1965, met Rafe Henderson [Ralph H.
           Henderson]. And he went off to Africa for a while and came back,
           and we got married in May of '66.
                 In October, we went off to Lagos, in Nigeria.
Decker:     Wow! So you were married in May 1966, and then in October 1966,
           you moved to Africa.
Henderson:  Yes, yes, we did.
Decker:     Wow!
Henderson:  And I started a journal.
Decker:     Oh, wow.
Henderson:  And I can't stop it, so I've been doing it ever since then.
Decker:     Forty years.
Henderson:  Yes. An interesting part is that we left Atlanta October 13,
           1966, and then we had the weekend off because the plane to Lagos
           left from New York. So we did this wonderful trip, well, Pan Am
           to Dakar, Roberts Field, stopping every few places, and we
           arrived on October 19 in Lagos. It was hot, humid, colorful,
           smelly, I'm saying. We got there at 2:00 pm, and we were very
           tired. The weather was hot.
                 We were provided with USAID [U.S. Agency for International
           Development] houses, which was like living in Florida, and we
           had a cook and a small boy and a gardener, a night watchman, and
           day watchman. So that's where it started.
Decker:     Wow! Did you write in your journal every day?
Henderson:  Yes. And this is 4 years on 1 page. Now I have 1 year on 1
           page.
Decker:     Wow! So, as newlyweds, what was the motivation for you and Rafe
           to pack up and to move to Lagos?
Henderson:  Well, he was an EIS [Epidemic Intelligence Service] Officer,
           and he came to Atlanta in July '65, and he did the usual EIS
           things. And then there were a couple of people, Mike Lane [J.
           Michael Lane] and Larry Altman [Lawrence K. Altman], who were
           already in West Africa, and I guess Larry was coming back. And
           they needed somebody else. So they said, "Do you want to go on
           this smallpox-measles thing?" And so Rafe did. He came back and
           married me.
Decker:     And when you got married, did you know that you were going to
           be going off to Africa, or was it a surprise?
Henderson:  Oh, yes. No, it wasn't a surprise..
Decker:     Was this your first time to Africa?
Henderson:  Yes.
Decker:     How much notice did you have between finding out that he wanted
           to go to Africa and your actually leaving? Did you have a lot of
           time to prepare mentally, physically, emotionally? Or was it a
           very quick transition?
Henderson:  At that age, you don't care about those things. You know,
           "Let's just go."
Decker:     Just do it.
Henderson:  Yeah.
Decker:     That's great.
Henderson:  I have a scrapbook in the meeting room where we got briefed.
           And we got French lessons, of course-we were going to Lagos,
           which is English-speaking. We got lists of things as to what we
           were supposed to take that's supposed to last us 3 years, as if
           we were going to the end of the world. Anything and everything.
           That was a summer of preparation.
Decker:     Okay. So it's just a few months.
Henderson:  Yes, July to October.
Decker:     So, then, what were some of the greatest challenges you faced
           upon arriving in Lagos?
Henderson:  The heat. Humidity. Not knowing where anything was; different
           money; the new languages being spoken around you.
                 Oh, and also, looking back, one flies a lot and one has
           colds in Lagos, and we had colds, and we had viruses, and we had
           diarrhea, and we had trots. In the 30, 40 years, I've only had 3
           bad attacks of diarrhea, whereas my husband had a lot more. And
           other people. I mean, in this group . . .
Decker:     Healthy bunch?
Henderson:  No, no. We had to take what we called Sunday-to-Sunday
           medicine, which is chloroquine every Sunday. One of our group
           said one of the side effects is going deaf, and Margaret Grigsby
           [Margaret E. Grigsby] did. Of course, now we don't take it
           anymore because it's not good. I mean, they said it developed
           resistance, so you had to take other things. It wasn't ever a
           normal life for me. We started the morning with salt pills,
           vitamins, and aspirin (because we rode around in trucks a lot
           and we got shook up).
                 The program covered 25 countries in West Africa, and
           everybody did not start work at the same time. There was a lot
           of travel for the regional office and people coming in and going
           out to the bush. So, we lived in Lagos, but it was mostly to
           regroup and wash up and then go out again.
                 What was real different with me was that we didn't have-we
           don't have-children, so if we had enough money, I could go with
           Rafe, and that was fantastic.
                 That s ort of subnormal life lasted until the end of April
           of '67, when Don Millar [J. Donald Millar] sent a cable saying,
           "You're supposed to be in Delhi with Dr.Lyle  Conrad and  Dr.
           Gordon Reid  to put out the smallpox epidemic in India,  like
           yesterday." (We called Conrad "Conree" because we combined the 2
           names.)
Decker:     So this was in May of 1967.
Henderson:  Yes.
Decker:     So you had been in Nigeria for less than a year. Right?
Henderson:  Yes.
Decker:     From October '66 through May '67. And then you went to New
           Delhi?
Henderson:  Yes, because, seemingly, India was out of smallpox vaccine, and
           theirs was the kind that you apply with a rotary lancet, which
           is really an instrument of torture. But D. A. Henderson [Donald
           A. Henderson] from Geneva had said that "we will give you all
           the vaccine you want, but you have to use the Ped-O-Jet." So he
           said, "We're going to send 3 people from CDC-Atlanta to
           vaccinate India."
                 Well, it turned out that that was the sort of
           demonstration project, vaccinating a whole lot of people like
           the police and the school kids. They were  all  already
           vaccinated, and that was what we did.
                 When they sent the vaccine, they forgot to include the
           diluent, and the first demonstration project too! Many of the
           public health people had been saying, "This is a test and it
           doesn't hurt." Well, the vaccinees were all cringing and
           grabbing their arms because the vaccine was reconstituted with
           water and not saline.
Decker:     Oh, because it was freeze-dried, and so you had to reconstitute
           it with saline.
Henderson:  So they had to make their own saline, and from then it went a
           little better. And it was pre-monsoon.  It was very hot and dry.
           .  Whereever we went, we were given tea or Orange Spot or Pop
           Cola or Pee Cola,  which tasted not so good, but, you know, it
           was liquid.  India  had thrown out Coca-Cola
.  So I think we survived that and came back to Atlanta for debriefing, and
that was one of those wonderful flights, like New Delhi, Tehran, Ankara,
Istanbul, Rome, New York. And we rushed from 1 plane to another and got
back to what was the Sheraton Emery back then. I think it was like a 33-
hour flight or something, so exciting.
Decker:     And when was this?
Henderson:  It was June 4, 1967. The next day, we had breakfast in the CDC
           cafeteria and lunch at CDC, and we slept a lot, and we're awake
           at 3:00 in the morning.
                 And the war in the Middle East was starting, and RFK
           [Robert Kennedy] was shot in L.A. And I guess we had a little
           vacation for some reason. Then, on June 23, Rafe went to Lagos,
           and I stayed here for some reason. And then, in July, I went
           back to Africa. And then the Biafran War started.
Decker:     So July 1967, you returned to Lagos.
Henderson:  Well, no, to Accra.
Decker:     To Accra first, and then Lagos?
Henderson:  No. I can't remember the date of the start of the Biafran War,
           but it looks like that was a time when dependents could not go
           back into Lagos because it was too dangerous. Although there was
           only 1 small plane that tried to bomb Lagos, and that didn't
           work too well.
                 So then Rafe was given or asked for a job to do
           assessments of the different programs in West Africa program. So
           I don't think I got back to Lagos. ..
                 This was really wonderful. This was sort of like camping
           out forever. But I didn't get back to Lagos for a long, long
           time, to the point where it was becoming financially difficult
           because we had to pay for my tickets, and Rafe was sort of at
           wit's end and saying, "I'm just going to quit because this can't
           go on." And then they said, "Well, do some more assessments,"
           and that worked out okay, and that was really a lot of fun in
           Niger and northern Nigeria and western Nigeria.
                 And the trucks breaking down. The Dodge trucks were
           guzzling gas and were not made  for the roads that were there.
           There was a trip from Niamey to Kaduna on which I think we broke
           like 5 things on the truck. Usually it was just washboard roads,
           you know, so you were really shook up all the time. But near
           Kaduna, there was a paved road or asphalt. But the truck was so
           bad that we couldn't hold it on the road, so we had to drive 2
           tires off the asphalt and 2 on. And by the time we got to
           Kaduna,, we drove up to Hogan's house  and they couldn't
           recognize us because we had red dust all over. Really fun.
Decker:     How exciting!
Henderson:  Yes. In western Nigeria, the assessment was during rainy
           season, so we got stuck coming and going. There's a picture
           downstairs where Rafe is crawling into the Dodge truck through
           the window. We went to a village-this famous survey where you
           pick out the village and you check people in  their houses  for
           vaccination scars. So there was this nice road, and then we got
           to what looked like a puddle, but it was big ruts, so we got
           stuck. And the villagers came and looked, and they said, "For 2
           pounds, we'll pull you out," and they did, and we were very
           thankful. We came back, and we got stuck again in the same
           place.
Decker:     Fifty pounds.
Henderson:  No, five.
Decker:     Oh, my.
Henderson:  And just some fantastic meetings of the emir of Yelwa, which is
           on the western part of the country. People were fighting over
           their land or their churches or whatever, like last year. But
           the emir back then, I guess he was 40, had been to Oxford, but
           he still wore his robes.
            In Yelwa, there were these fantastic markets, where all kinds
           of people gathered and we did market surveys. I helped a little
           bit, to look at arms. And the first group was usually the
           butchers because they were the first ones in the market. The
           meat was all raw, and ever since then, I really like it well
           done. And they were very accommodating. It was a cold  early
           morning, so the people wore many layers, and you had to stand
           there, and the aroma of the meat was overwhelming,  until  till
           they took  off  all the layers of clothing so we could see their
           arm with the vaccination scar. But other people then started
           coming. The busiest time, I guess, was between 11:00 and 2:00,
           when the sun is at the hottest. And most of the different groups
           didn't mind showing their arms. Except we met some ladies. Now
           we'd say they were dressed in leather miniskirts with cowry
           shells. I don't think they had spears, but they had some kind of
           a weapon. And, of course, they wouldn't, certainly, let us look
           at their children. And they didn't talk to us, and we knew not
           to ask if we could take their photo because they were really
           tough.
Decker:     Was this in Yelwa?
Henderson:  Yes, the Yelwa market.
Decker:     So you were really on the front lines with Rafe the whole time?
Henderson:  Yes, I guess partially because of the Biafran War.
Decker:     So you got to see everything that he got to see?
Henderson:  Yes.
Decker:     Instead of staying isolated in a compound somewhere.
Henderson:  With air-conditioning.
Decker:     How interesting. You're my kind of woman. I like that; I
           definitely like that. So, some of the challenges. . . Did you
           have to learn how to fix the Dodge trucks yourselves?
Henderson:  No. They did.
Decker:     They being the men?
Henderson:  Well, you finally had to rely on the driver because the driver
           was the most competent. I mean, some of the people who went,
           like Rafe, could kick the tire and look under the hood. Although
           once we broke down in a rubber plantation in Sierra Leone or
           Liberia. There was this feeling that we'd been losing brake
           fluid, and eventually the brakes didn't work. So what they
           discovered was that the Dodge was designed where the brake-fluid
           line was right next to the engine block, so of course when you
           shook on the washboard roads, it eventually would rub a hole in
           there. So, what do you do?
                 Well, we had a first-aid kit which had cotton, and we
           found some thin rope somewhere, and we said, "Well, that won't
           do. But, look, there's a rubber tree, with rubber." So they got
           some rubber and cotton, and then they wound the twine or the
           rope around the line, and it held for some time.
Decker:     So you bit off part of the rubber tree, chewed it off?
Henderson:  No. The rubber itself, because they tapped the rubber tree.
Decker:     Oh, and it's like syrup, it's sap.
Henderson:  It's like chewing gum, almost.
Decker:     That's right. That's a great story, that's a great story.
Henderson:  All true.
Decker:     So, when you went back in '67, back to Lagos finally, that's
           when you started traveling around the region?
Henderson:  No, it was before that. It was from the time after India, after
           Atlanta, and then we started traveling.
Decker:     Okay. And then, after the travels around the region, you came
           back to Lagos?
Henderson:  Yes. And it was nice to meet all the MOs [medical officers] and
           the OOs [operations officers] everywhere. There was something
           about Jay Friedman [Jay S. Friedman] bellowing for his driver
           named Benson  , who was supposed to come pick him up. The driver
           finally showed up and he said, "Well, my watch didn't work,"
           which was not  exactly right. . .
                 And in western Nigeria, I think we did part of the
           assessment iduring the war with Biafra, so there were roadblocks
           everywhere, every few miles, manned by the local police and
           usually drunk soldiers. And they didn't get along among
           themselves very well. And there was, of course, a curfew.
           Wherever you were going, you had to be there by 7 pm. So when
           you get stuck in mud on the road and you can't quite get out . .
           .
                 We had 1 very uncomfortable checkpoint stop where the
           police and army were arguing with each other. We had to take
           everything out of the truck, and they went through everything.
           And I think one probably wanted a little gift, and  they
           couldn't agree, until Rafe finally said, "This is an American
           Embassy vehicle, and I need your names because I have to make a
           report," so that sort of stopped them. And they thought a bit
           and they said, "Look, just go on."
Decker:     Oh, so you were in an embassy vehicle, or did you just make it
           up?
Henderson:  No. Well, I guess, you know, USAID is part of the government.
Decker:     That's true.
Henderson:  And the embassy is our thing in the country, so, yeah.
Decker:     Clever, very clever. So, what were some of the challenges of
           working with your local country counterparts? I mean, you talked
           about some of the physical challenges of living in Africa. What
           about the interpersonal relationships with the Nigerians?
Henderson:  The regional office was regional, so the Nigeria program was a
           country program.
Decker:     Oh, okay.
Henderson:  Dr. Foster [Stanley O. Foster] and Dottie [Dorothy Foster] were
           working with the Nigerians, so we really didn't interact with
           the Nigeria program.
Decker:     Oh, you didn't. Okay.
Henderson:  Well, at dinners and receptions. And I'm sure Rafe had some
           interaction, but that was a big program. Nigeria is a big
           country, so it was Dr. Foster who did it. Well, whenever we went
           to a country, we'd stay with either the MO or the OO. It was
           just wonderful: an exhausting day and a delicious dinner and
           fall in bed.
Decker:     So your husband was the regional epidemiologist? Is that
           correct?
Henderson:  He was Deputy Director of the regional office. And George
           Lythcott was the Director. And Don Millar was the counterpart
           here in Atlanta, and then D. A. Henderson in Geneva.
Decker:     Okay. Were you and your husband actually administering
           vaccinations yourselves, or were you supervising teams that were
           doing that?
Henderson:  I didn't. I took pictures and observed the ambiance.
Decker:     Have you written a book, published a book?
Henderson:  No. This "Any Year Diary" I am holding,  is my book.
Decker:     It sounds like you have amazing  memories.. . .
Henderson:  The OOs and the MOs were all epidemiologists. So when Rafe went
           to a country, he'd make a checklist as to whatever was going on
           and the problems, the accomplishments, the unsolvables, all
           that. And , we all  would volunteer , sometimes, to be
           vaccinated. I've been vaccinated so much. So that was my only
           involvement.
Decker:     Okay. Can you describe a typical day, or was every day
           different?
Henderson:  Every day is different.
Decker:     Every day is different. So you were always moving around?
Henderson:  Yes.
Decker:     So, then, was it difficult, I suppose, to form attachments with
           local friends?
Henderson:  Well, not in those years in West Africa because we were all
           friends. We were all like a big team. No, that was no problem.
           It was a unique experience and situation.
Decker:     What are some of the things that you or your husband would have
           done differently, looking back on the program today? I mean,
           obviously, it was a great success. But are there any elements
           that you would have changed if you could do it again?
Henderson:  Probably the orientation wasn't that realistic. But in any
           travel, they give you a sheet of things that are supposed to go
           on, I mean, and it doesn't really. And I don't think anyone can
           really know, unless they send someone to do exactly what you're
           going to do and they come back and they report. But their report
           sometimes is very different from what really goes on on the
           ground.
                 Back then there were no emails. Phones didn't work very
           well. I think if you'd called from Lagos to Cotonou-which is
           like, what? an hour away or so?-the call went from Lagos to
           London to Paris to Cotonou because the French had their system
           and the British had their system. And there were no satellite
           phones, of course. The mails were not reliable. So communication
           is always a problem. And when there's that breakdown, people in
           Atlanta had a different idea of what was going on in West
           Africa. And, of course, we thought the Atlanta people really
           didn't care much about us. That's putting it politely.
Decker:     Yeah.
Henderson:  And we had broken equipment. I mean, the trucks just weren't
           meant for West Africa. There were many times the Land Rover had
           to pull us out. Just to get spare parts . . . And there was a
           time we broke an axle-I mean, everybody was breaking axles, and
           it happens on a washboard road out in the middle of nowhere. And
           finally somebody comes by and pulls you into a town, and then
           you get a         cable from Atlanta saying, "Well, 3 months to
           get a new axle."
Decker:     And what do you do?
Henderson:  Well, you can raid another truck, that kind of thing.
                 And, when Atlanta  came to West Africa, but it was rather
           ceremonial. I mean, they came for, I guess, the ten-millionth
           vaccination and the twenty-fifth million.
Decker:     I read about the ceremony that they had,
Henderson:  That was very good.
Decker:     They had a big observance: they vaccinated a young girl.
Henderson:  Yes. I was there.
Decker:     Could you describe that day or the event?
Henderson:  Oh, it was fantastic! Other than hot. It was a little bit up
           from Accra, so maybe it was higher, so it wasn't so humid. But
           all the chiefs were coming in. Each chief was under a ceremonial
           umbrella, of course, just red and gold-I guess Ghana used to be
           called the Gold Coast. These umbrellas were like what we have on
           our patios. And, of course, the chiefs were preceeded by the
           bearer and the person who carried the paramount chief's insignia
           and all that, and then probably a praise singer. Finally they
           got seated, and somebody had to hold the chief's arms because
           they were so weighed down in gold. And then we all sort of filed
           by and shook hands. And that's when the visiting  cards were
           exchanged.
            And the drumming and the dancing! There was a group of women
           who pulled my husband into their midst and formed a sort of a
           circle, and I think they took turns dancing with him. I'd better
           not describe them, but they liked my husband.
Decker:     So it was a big event.
Henderson:  Yes.
Decker:     And the folks from Atlanta, like Dr. Sencer [David J. Sencer],
           flew in.
Henderson:  Millar, Dr. William  Stewart,  the Surgeon General of the
           United States, then.
Decker:     Oh, right.
Henderson:  And here are just wonderful pictures. [she is showingpictures]
Decker:     That's the Ogden book that you're showing me?
Henderson:  Yes, it is. It's the 10th anniversary.
Decker:     Okay. I just got done reading that book.
Henderson:  A letter from Billy Griggs is saying, "Sorry that you couldn't
           be with us," December 2, '87. And then James Mason, the CDC
           Director, was talking about the smallpox warriors in a special
           exhibit.
Decker:     Wow! Is this a letter that you would be willing to photocopy
           and give to the museum?
Henderson:  Sure.
Decker:     Okay.
Henderson:  And this mentions, in the first paragraph,  the people who
           came. And here is a picture of the 3 instruments for vaccinating-
           the rotary lancet, jet gun, and the bifurcated needle. And this
           is where they're learning to repair Dodge trucks.
Decker:     So your husband was in one of photos?
Henderson:  Right there. And Bill Foege [William H. Foege].
Decker:     So you're all just young-young, fresh, energetic. That's great.
           What an experience. How many years total were you in Nigeria and
           the region?
Henderson:  Three.
Decker:     Three. So you came back in . . .
Henderson:  July of '69.
Decker:     '69, okay. So I read that Nigeria was smallpox-free by May
           1970. So you came back before it was completely eradicated.
Henderson:  Yes, because things were slowing down.
Decker:     Okay. It was just that final little pocket in Nigeria.
Henderson:  Yes.
Decker:     Okay. So, at what point did you actually think or believe that
           the smallpox would be eradicated?
Henderson:  Day 1.
Decker:     Day 1! So you were an optimist from the get-go.
Henderson:  Well, I think everybody thought that, except for maybe Millar,
           and,  D.A. I don't know.
Decker:     Did you recognize the magnitude of what you were trying to
           accomplish at the time, or only years later?
Henderson:  Well, it's a horrible disease, and to see what it was doing to
           the villagers. There was  one  village that we went to, with
           either Jean Roy [Jeannel A. Roy] or Andy Agle, that had a
           smallpox epidemic. I don't know how many died. And the chief
           felt so responsible for it, felt that the smallpox was his
           fault, that he burned down his house. And he didn't have very
           much to start with.
                 And in India we saw hemorrhagic smallpox, which is just on
           the skin. It's like having very thin skin. All the capillaries
           are just about to burst. The hospital in Delhi had a special
           ward for the people. It's an awful, awful disease.
Decker:     Was there an understanding among the folks on the ground of how
           smallpox was transmitted?
Henderson:  Well, not in those words, no.
Decker:     What was the local understanding of the disease?
Henderson:  If you go to the village level, it's just something that comes
           every year or every so many years. That's just part of life.
Decker:     Was it attributed to a particular god or act or witchcraft? Is
           there a way that people explained the disease?
Henderson:  Well, we really never got into it too much because you had to
           have several interpreters. And by the time the answer came back,
           it probably is not what was said at the end of the line. So I
           don't know.
Decker:     That's the anthropological side of me probing you here.
Henderson:  Well, Nigeria, or the Yorubas - Lagos, in Aboekuta, , Ibadan,
           had a smallpox cult that had been going for several hundred
           years probably. And maybe the priests or the Fetisheurs had been
           using variolation  because they didn't get smallpox. So they
           could say, "Well, I'm the special person, and the chief of
           smallpox, but if you give me some gifts, maybe smallpox will not
           attack you. There are 2 kinds of smallpox; with one, your skin
           will break out; with the other, your mind is affected. So a
           little gift would help. And if it doesn't, then I'll just take
           care of you after you're dead. But I will need to be paid with
           your possessions." The British finally outlawed the cult, I
           guess, in 1905, but they had some outbreaks after that. Shapona
           is supposedly the smallpox god. The Fetisheur has a little sort
           of a shrine where he has the god, a special smallpox pot, and
           bottles of gin and vodka and things like that. I have a history
           of the Yorubas that I bought in a market.
            We all loved markets. Other than checking for vaccination
           coverage, I mean, they're just vibrant places and had wonderful
           stuff. There's the medicine and the Juju [phonetic] part of it,
           and all of the different things you can eat from these huge
           snails that must weigh 3 or 4 pounds, dried rats, and all the
           delicacies.
Decker:     Were you able to partake in eating all of the delicacies? Did
           you tend to live an American lifestyle in terms of diet, or did
           you jump into the culture with both feet?
Henderson:  Well, what is that thing that CDC travel book says, unless you
           cook it, peel it, or  -you know, the 3 things-you don't touch.
           And, well, it's not comfortable to have a lot of diarrhea
           attacks, so one sort of watched. But we also went to the
           restaurants. The dishes I cook with  ground nuts, too, they're
           just wonderful. Curries, West African curry, just different from
           Indian curry, somewhat. Brochettes of things, frog's legs,
           shrimp, barbeques. In northern Nigeria, they had too many
           peanuts, so the hogs were fed on peanuts, so that was a very
           good.
Decker:     You can tell it's close to lunchtime now. I'm talking about the
           food.
Henderson:  Well, yes, the food. And then, of course, there was English
           food, which wasn't so great. But the French, Lebanese, was just
           wonderful stuff. I was going to say that we should have tried
           more-well, we did, we did, but we didn't eat things off the
           street. I didn't think that was the best. And even then, I got
           diarrhea. My first diarrhea attack occurred in Accra, between
           the jet-gun demonstration in January and the 25th millionth
           vaccination. It was bad, and I took too many Lomotils, and I
           think I slept probably a whole day.
Decker:     Did you have major illnesses while you were there or just
           mostly routine diarrheas?
Henderson:  Diarrheas, colds, feeling, I guess Brits say, seedy, lousy.
                 I think my husband probably had typhoid fever between Lome
           and Niamey. Maybe that's why he left me somewhere, and he went
           off to Lagos. But, well, I guess it was Niamey where the Peace
           Corps doctor had this big book of tropical diseases. I went down
           to look in it to see what he could have because he'd been
           treating himself, thinking he had malaria and he didn't. So he'd
           be okay one  day, and the next day he would be just shaking.
           There was a nurse who said, "Well, I've met some typhoid people,
           and sometimes they just jump out the window, it's so bad." But,
           luckily, the Peace Corps doctor had Chloromycetin, so Rafe got a
           dose of that, and I think I got some, and he recovered.
                 Well, at that age, you don't think that health is that
           important. I think it's only after retirement, that that sort of
           hits people, things that should have been looked at before, like
           prostate cancer, colon cancer. I don't know if anyone had lung
           cancer in the group. But back then, we were invincible.
Decker:     During the time that you were actually in the field, were there
           moments that you had regrets or feelings such as, "What am I
           doing here? Why did we do this?"
Henderson:  No.
Decker:     No regrets. That's fabulous, that's fabulous.
                 So, it seems like such a silly follow-up question, but in
           what ways did this experience as part of the project for these 3
           years change your life?
Henderson:  We got sent to Geneva, Switzerland, to WHO [World Health
           Organization].
Decker:     Oh, okay.
Henderson:  So we got back here in '69. Then Rafe got 2 more degrees, an
           MPH and an MPP [Master of Public Policy] from the JFK School.
           And then he came back to Atlanta, and he was given several
           projects. One involved blood in labs, I think; I can't remember.
           There's some blood network. It's not the Red Cross. And then Dr.
           Sencer thought that we should get some taste for how Washington
           is run, so we spent the summer there. And then we came back and
           Rafe started supervising the Venereal Disease Division.
           Eventually, the name was changed to Sexually Transmitted
           Diseases, and the list of diseases enlarged from just 2-
           gonorrhea, syphilis-to all the others, ending with unwanted
           pregnancy. Guess one shouldn't talk about that. And that lasted
           from '72 to '77.
                 And in January of '77, Dr. Sencer said, "WHO needs an
           American to create the Expanded Program on Immunization for WHO,
           so do you want to go?" So Rafe said, "Oh, yes," and he spent the
           month of January in Geneva justifying why he was capable of
           doing it and why he would want to do it because WHO had many
           experts, over 50 or so, because they'd done everything and they
           knew everything, and then this young American comes.
Decker:     And Rafe was in his 30s, right?
Henderson:  Yes. And so, finally, they said, "Well, okay." I think D. A.
           Henderson was coming back, and that created the slot. And Rafe
           came back, I think, the end of January of-this is not the book;
           I have another book.
Decker:     You must have a line of books in your house.
Henderson:  I do, yes. I think I'll have a bonfire or something.
Decker:     No. You should donate them.
Henderson:  Yes, well.
Decker:     It depends on your secrets.
Henderson:  No. Most of them are in a code.
Decker:     Oh, that's good.
Henderson:  But it was a Saturday, and, Rafe was in Geneva. Back then CDC
           was smaller.              . Jane and Dave Sencer were really
           taking care of everybody and supervising and giving wonderful
           dinners.   Dr. Sencer came back from Washington. And this was
           after the swine flu problem. He'd been up there to brief Hale
           Champion, who was Undersecretary of Health and Human Services,
           Health, Education and Welfare, I guess. Dr. Sencer had been
           briefing him, and he was about to go out the door, and Hale
           Champion said, "By the way, you're fired."
Decker:     Wow!
Henderson:  So Dr. Sencer came back, and there we were all going to have a
           nice, joyful party, and that certainly put a damper on things.
           A few days later, Rafe came back, and CDC decided he could still
           go to Geneva, and they gave us a month to pack up and go, and we
           did. We went for 2 years, and the contract was renewable every 2
           years, so if WHO and CDC were happy with Rafe, and Rafe was
           happy, it was renewed. So we stayed for 23 years.
Decker:     Oh, my. Are you still there? No.
Henderson:  No. We came back October 1, 1999.
Decker:     Wow! What an exciting life!
Henderson:  And the interesting thing is that, after the smallpox program,
           there were all these - in the states and other places.  WHO
           turned out to be a place that had abbreviations for everything
           and they called  the  Expanded Program on Immunization EPI. ,
           The old smallpox people  were very valuable, so they were coming
           through EPI all the time. So smallpox and EPI sort of runs
           together to me, and I can't tell sometimes who's who.
Decker:     They view your experience in one, not into the next experience.
Henderson:  Well, the OOs and the MOs, that's what they did. They were
           valuable in running vaccination programs. So they had this
           expertise that WHO didn't have.
Decker:     So WHO needed them for their next thing?
Henderson:  And, well, Jean Roy is still running around doing that, and he
           works for the Red Cross and Red Crescent Societies, whose
           headquarters are in Geneva.
Decker:     I understand that you're trained as a pharmacist?
Henderson:  Yes.
Decker:     Do you practice as a pharmacist?
Henderson:  No. I retired in July of '66.
Decker:     Good for you!    Had you practiced before you retired?
Henderson:  Yes. I was a pharmacist at Emory University  Hospital pharmacy,
           and I should have worked about 4 more months so I would get full
           Social Security, but I didn't, so mine is half of what my
           husband is.
Decker:     Wow. Did you ever feel that because you were going where your
           husband was going, you missed out on your own career?
Henderson:  No, because the West Africa experience was so unique. Who wants
           to have a 9-to-5 job if you can do that?
Decker:     That's true.
Henderson:  And then coming back here for a few years was very nice. And
           then the EPI experience. I think I said before that I don't want
           to travel. I've had it. And I don't want to go camping. The only
           places I haven't been, I guess, are South America and China,
           Mongolia. We had a big network of friends; some of them, as I
           said, were from the Smallpox Program and some new ones.
            I went to so many meetings. And I wasn't welcomed everywhere at
           the meetings. Finally, we hit upon Rafe's introducing me as his
           personal assistant, instead of as his wife. There was no problem
           with that because there were other people who took people along
           who weren't exactly their wives. But, no, that was fantastic.
Decker:     Wow. So you were definitely a member of the team.
Henderson:  Yes, in a sense as being a personal assistant, taking
           photographs. Well, I'm also sort of a people watcher, and it's
           wonderful to see the people, what they say and what they do and
           how they perform.
Decker:     Did you have an opportunity to learn any local dialects?
Henderson:  No. We weren't there long enough.
Decker:     You were moving around too much. Well, you've done amazing
           things.
Henderson:  I wonder if I've forgotten something I wrote down but no,
           probably not.
Decker:     One of my last questions was actually going to be whether or
           not you would like to add anything that we haven't discussed?
Henderson:  I think the EPI experience is interesting.
Decker:     The EPI is the one in Switzerland?
Henderson:  No, global.
Decker:     Oh, the global, okay. You'll have to forgive me with the
           acronyms because I'm on the academic side over here with
           historians. But what incredible opportunities you've had.
                 Is there a particular story that you can conclude with, of
           like the greatest challenge or the toughest moment or the most
           exciting moment?
Henderson:  All of those!
Decker:     And it all happened on 1 day.
Henderson:  Just about.
Decker:     Were you able to stay in contact with your family back in the
           United States?
Henderson:  Yes. At first it was just postcards. I have them on the
           desk.downstairs. And then I took home leave every 2 years. I
           would visit everybody for 2 weeks, and then collapse,
           emotionally, psychologically, and physically. And airplane
           travel isn't that great. But then it used to be better.
                 But 1 thing I forgot: Rafe and I developed a hobby that we
           both participate in. The thing is that it's a hobby that you
           have to do together. It's bird watching. It started in Lagos. In
           Lagos, it would be dark and all of a sudden it would be sunny.
           And then in the evening, 6:00 sunset.
Decker:     Yes, the 12-hour days.
Henderson:  So we would be woken up to this bird outside our window-well,
           our windows were closed, but it was loud enough. And the bird
           was saying, "Quick, doctor, quick!" and it kept on and on and
           on. And Rafe said, "What in the world?" Well, it was a bird.
           Luckily, there was a little book that we found, The Birds of
           West Africa, I think, and it had that bird in it. It was a
           common bulbul, and it's the Omar Khayyam's  nightingale. It's a
           nondescript bird, and it's not like the European nightingale.
           And then we saw all these other birds out there in the garden,
           and sure enough, they were in the book. They were all colorful
           and loud and great. And from then on, we started birding, and
           now we do that.
                 We always had been members of the Georgia Ornithological
           Society. They have a spring meeting and a fall meeting and a
           winter meeting in different places in Georgia. So now that we're
           back here, we're going bird watching and we meet these
           unbelievable people who just know what's what and hear a sound,
           and they say, "No, that's not it. That's what that is."
Decker:     So you traveled the world and found .
Henderson:  Yes, but this is just in Georgia. In August, we're going to
           Jekyll, Tallahassee, Kennesaw, Columbus. We don't do all the
           canoeing and kayaking, and we're not that good, because each
           continent has different birds, but we're learning.
Decker:     What a fun hobby.
Henderson:  Yes. Oh, the thing is that if you see a bird and you say that's
           what it is, well, someone has to agree with you, so that's the
           hobby that we can do.
Decker:     And do you ever fight over it?
Henderson:  Yes.
Decker:     And who's right?
Henderson:  This spring, he was. He saw an orange-crowned warbler, and you
           can't see a crown and it's not orange, but that's what it was.
Decker:     That's great. So Africa comes back to you again. Well, thank
           you so much.
Henderson:  Well, thank you.
Decker:     Thank you for your stories, thank you for your time. You're
           just a firecracker.
Henderson:  Yeah, on vacation.
Decker:     Yeah, well, that's great. So thank you for your time.
                                    # # #
&lt;/pre&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="86">
          <name>Player</name>
          <description>html for embedded player to stream video content</description>
          <elementTextContainer>
            <elementText elementTextId="65183">
              <text>&lt;iframe width="100%" height="166" src="https://w.soundcloud.com/player/?url=https%3A//api.soundcloud.com/tracks/310125697&amp;amp;color=ff5500&amp;amp;auto_play=false&amp;amp;hide_related=false&amp;amp;show_comments=true&amp;amp;show_user=true&amp;amp;show_reposts=false" frameborder="no" scrolling="no"&gt;&lt;/iframe&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42566">
                <text>text</text>
              </elementText>
              <elementText elementTextId="42567">
                <text>interviews</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42568">
                <text>2006-07-13</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="42569">
                <text>http://pid.emory.edu/ark:/25593/158jd</text>
              </elementText>
              <elementText elementTextId="42570">
                <text>emory:158jd</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42571">
                <text>WHO</text>
              </elementText>
              <elementText elementTextId="42580">
                <text>Biafra War</text>
              </elementText>
              <elementText elementTextId="42581">
                <text>Life as expatriate wife</text>
              </elementText>
              <elementText elementTextId="42582">
                <text>CDC</text>
              </elementText>
              <elementText elementTextId="42584">
                <text>USAID</text>
              </elementText>
              <elementText elementTextId="42585">
                <text>Smallpox Eradication</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42572">
                <text>699002640 bytes</text>
              </elementText>
              <elementText elementTextId="42573">
                <text>audio/x-aiff</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42574">
                <text>Decker, Alicia (Interviewer); Emory University; Graduate Student</text>
              </elementText>
              <elementText elementTextId="42575">
                <text>Henderson, Ilze (Interviewee); CDC; Wife of Deputy Director of Regional Office</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42576">
                <text>Centers for Disease Control</text>
              </elementText>
              <elementText elementTextId="42577">
                <text>Reunion of West and Central Africa Smallpox workers (2006 : Atlanta, Georgia)</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42578">
                <text>HENDERSON, ILZE </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42579">
                <text>Ilze Henderson, wife of Rafe Henderson who served as Deputy Director of Regional Office, in Nigeria.  Ilze  tells of immigrating from Latvia to the United States and meeting her husband, Rafe, during college and moving to Lagos, Nigeria shortly after they married. Ilze went with Rafe on assignment to India, and then back to Nigeria. Ilze speaks of the Biafra War in Nigeria, traveling with her husband on assessment surveys, adjusting to life as an expatriate, Rafe's later career with CDC and WHO, and life and hobbies since the years spent working on smallpox eradication.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42583">
                <text>English</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
  <item itemId="5330" public="1" featured="0">
    <fileContainer>
      <file fileId="3540" order="1">
        <src>https://www.globalhealthchronicles.org/files/original/f2f26a6dd20ab344b90031f2ab88d350.jpg</src>
        <authentication>f2ba8e7c3ea456bfd6f16ff1ca4dca2b</authentication>
      </file>
      <file fileId="2838" order="2">
        <src>https://www.globalhealthchronicles.org/files/original/35e4e0cbe1eb945418410dfb4594ca53.pdf</src>
        <authentication>0633e9098537d49867bb7050d97e1576</authentication>
      </file>
    </fileContainer>
    <collection collectionId="1">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64878">
                  <text>Smallpox</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64879">
                  <text>&lt;div class="landing"&gt;
&lt;p&gt;Smallpox disease was declared eradicated in 1980, the result of a collaborative global campaign. To date, it is the only disease affecting humans to be eradicated from the world. Global eradication of smallpox ranks among the great achievements of humankind. Gone, through determined human effort, is a disease which has brought death to millions, frequently altering the course of history, and traveling through the centuries to every part of the world.  &lt;/p&gt;
&lt;p&gt;The vital contributions made by the Centers for Disease Control and Prevention are highlighted. Official government correspondence, meeting transcripts, policy statements, surveillance reports and mortality statistics tell a part of that story. Adding depth to these traditional archives are the personal stories of the public health pioneers who worked tirelessly on the frontlines of the smallpox eradication campaign.&lt;/p&gt;
&lt;p&gt;The links above connect you to a database of oral histories, photographs, documents, and other media.&lt;/p&gt;
&lt;p&gt;Use of this information is free, but please see &lt;strong&gt;“About this Site”&lt;/strong&gt; for guidance on how to acknowledge the sources of the information used&lt;/p&gt;
&lt;/div&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="17">
      <name>Moving Image</name>
      <description>A series of visual representations imparting an impression of motion when shown in succession. Examples include animations, movies, television programs, videos, zoetropes, or visual output from a simulation.</description>
      <elementContainer>
        <element elementId="11">
          <name>Duration</name>
          <description>Length of time involved (seconds, minutes, hours, days, class periods, etc.)</description>
          <elementTextContainer>
            <elementText elementTextId="56994">
              <text>1:37:40</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="86">
          <name>Player</name>
          <description>html for embedded player to stream video content</description>
          <elementTextContainer>
            <elementText elementTextId="65181">
              <text>&lt;iframe src="https://w.soundcloud.com/player/?url=https%3A//api.soundcloud.com/tracks/310213455&amp;amp;color=ff5500&amp;amp;auto_play=false&amp;amp;hide_related=false&amp;amp;show_comments=true&amp;amp;show_user=true&amp;amp;show_reposts=false" frameborder="no" scrolling="no" width="100%" height="166"&gt;&lt;/iframe&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="64231">
                <text>HENDERSON, RAFE &amp; ILZE </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="64232">
                <text>Dr. Ralph "Rafe" Henderson talks about his public health career at CDC and the World Health Organization. He and his wife, Ilze, who was a tremendous help to him and kept a journal of their travels and work, were primarily stationed in the field working on infectious diseases, especially smallpox eradication.&#13;
&#13;
Interviewed by Karen Torghele</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="64233">
                <text>The David J. Sencer CDC Museum at the U. S. Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333&#13;
www.cdc.gov/museum&#13;
</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="64234">
                <text>February 3, 2012</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
  <item itemId="3525" public="1" featured="0">
    <fileContainer>
      <file fileId="3293" order="1">
        <src>https://www.globalhealthchronicles.org/files/original/e7e81b68fcf0968506a76bad6f69091e.jpg</src>
        <authentication>0929000669383a01f855c8d9ec805ee0</authentication>
      </file>
      <file fileId="3541">
        <src>https://www.globalhealthchronicles.org/files/original/20bde83a0bf8cc195ef1f2909f16b36f.pdf</src>
        <authentication>dde2403f413cec4e8af73567f2080cec</authentication>
      </file>
    </fileContainer>
    <collection collectionId="1">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64878">
                  <text>Smallpox</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="64879">
                  <text>&lt;div class="landing"&gt;
&lt;p&gt;Smallpox disease was declared eradicated in 1980, the result of a collaborative global campaign. To date, it is the only disease affecting humans to be eradicated from the world. Global eradication of smallpox ranks among the great achievements of humankind. Gone, through determined human effort, is a disease which has brought death to millions, frequently altering the course of history, and traveling through the centuries to every part of the world.  &lt;/p&gt;
&lt;p&gt;The vital contributions made by the Centers for Disease Control and Prevention are highlighted. Official government correspondence, meeting transcripts, policy statements, surveillance reports and mortality statistics tell a part of that story. Adding depth to these traditional archives are the personal stories of the public health pioneers who worked tirelessly on the frontlines of the smallpox eradication campaign.&lt;/p&gt;
&lt;p&gt;The links above connect you to a database of oral histories, photographs, documents, and other media.&lt;/p&gt;
&lt;p&gt;Use of this information is free, but please see &lt;strong&gt;“About this Site”&lt;/strong&gt; for guidance on how to acknowledge the sources of the information used&lt;/p&gt;
&lt;/div&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="17">
      <name>Moving Image</name>
      <description>A series of visual representations imparting an impression of motion when shown in succession. Examples include animations, movies, television programs, videos, zoetropes, or visual output from a simulation.</description>
      <elementContainer>
        <element elementId="5">
          <name>Transcription</name>
          <description>Any written text transcribed from a sound.</description>
          <elementTextContainer>
            <elementText elementTextId="42933">
              <text>&lt;pre&gt;&lt;strong&gt;
 Interview Transcript
&lt;/strong&gt;
This is an interview with Dr. Ralph H. "Rafe" Henderson, about his role in
the West African Smallpox Eradication Project of the Centers for Disease
Control. Today is July 7, 2006, and this interview is being conducted as a
part of the 40th anniversary reunion of the launching of the Smallpox
Eradication Project. The interviewer is Victoria Harden.

Harden:     Dr. Henderson, I want to begin by setting the stage for who you
           were in the smallpox project, and I'd like to start at the
           beginning. If I am correct, you were born in New York City, on
           March 5, 1937. Would you give me a brief account of your
           childhood and education, who your parents were, and whether any
           of these early experiences nudged you towards medicine or public
           health?
Henderson:  Yes. My father was born in Burma, which is the explanation for
           my nickname, Rafe. The British soldiers in Burma, who were then
           in charge, used Rafe as a nickname for Ralph. My father's name
           was also Ralph, and when he named me Ralph, then they called me
           Rafe as a nickname. So that explains that. But it also explains
           my orientation for international health. My grandparents were
           medical missionaries; their grandparents were also medical
           missionaries in Jamaica. My uncle was a medical missionary in
           China. My father was the black sheep of the family: he went into
           publishing with the Reader's Digest.
                 But my brother and I became physicians. When I was doing
           my internship at Boston City Hospital, I was contacted by
           somebody from CDC, who told me about the Epidemic Intelligence
           Service (EIS). And that, combined with a lot of my other
           interests in the international sphere and missionary work-
           although my father was not religious and I'm not particularly
           either-seemed to be a very good next step for my career in
           public health.
Harden:     Let's drop back a little bit and ask you to talk about your
           years at Harvard. You were at Harvard for both your
           undergraduate education and medical school. Was there anybody on
           the faculty who was particularly important to your career?
Henderson:  Yes, obviously in college, one always has heroes. Mine was a
           psychologist named Jerry Bruner [Jerome S. Bruner], who was
           dealing with cognitive psychology, and I found that very
           interesting. I won't tell you the funny things we did, but in
           any case, it was an interesting time at Harvard. I was there
           only 3 years because I had spent the year before going to
           Harvard as an exchange student for the English-Speaking Union.
           So I was in the U.K. for a year, in what was a public school,
           before coming to Harvard, so I was only at Harvard for 3 years.
           Then I went on to medical school.
                 In medical school, many of us were very, very influenced
           by Professor Thomas Weller, who had worked with Enders [John
           Franklin Enders] and Robbins [Frederick C. Robbins] in
           developing the polio vaccine and later on the measles vaccine.
           Weller was very eloquent about tropical public health and the
           challenges and the needs that were going on. As I say, a whole
           bunch of us came out from under his tutelage very interested
           (well, let's say interested because we were too young to be
           career-committed at that point). I think he was a strong
           influence.
Harden:     You joined CDC immediately after your internship and residency
           in Boston City Hospital. Were you one of the folks joining
           initially to avoid-pardon me, to discharge-your military
           obligation?
Henderson:  Well, I think "avoid" is a very good term because I think for
           many of us, that was 1965, '64, '65, when the Vietnam War, was
           just starting. And how does one want to spend one's military
           career? Well, it was certainly a very easy choicevivid  one for
           us. I would like to think that my own reflexes-both seeing the
           difficulties of practicing in a city hospital, where you're
           seeing end-stage disease and not being able to do very much
           about it, and my interest in international health-made CDC a
           choice whether or not there had been a military draft. But it
           was clear that that served the best of all purposes as far as I
           was concerned. I was not interested in serving in other areas of
           the military. I was very interested in serving in what I knew,
           at that point, CDC was doing.
Harden:     In public health service.
Henderson:  Right.
Harden:     So in 1965 and '66, you were an EIS Officer. Would you talk a
           little bit about your EIS training and assignments?
Henderson:  Well, it was incredible. In those days, they used to call the
           interns "the iron men" because we didn't get salaries, we ate at
           the hospital, we often slept at the hospital, we had 1 set of
           clothes. But we came to Atlanta and we're presented with a slide
           rule; we got a salary; we were treated like important
           individuals. It was incredible. Absolutely incredible. And we
           had a very exciting 6-week EIS course, training us in shoe-
           leather epidemiology. Because of my interest in international
           health, I applied to the smallpox unit. I was lucky enough to be
           selected. And then, lo and behold, I was sent off, very shortly
           after the training, to West Africa as a technical advisor to the
           French public health organization in the western part of West
           Africa, called the OCCGE [Organization de Coordination et de
           Cooperation pour la Lutte contre Grandes Endemies]. That's a
           very long name, but part of it, the Grands Endemies, translates
           into the "great endemic diseases."
                 I have to back up a couple of steps to explain why I was
           going over there. In about 1963, roughly, the NIH [National
           Institutes of Health] conducted a major field trial of measles
           vaccine in West Africa, beginning in Upper Volta, as it was
           called. And it was an astounding success. They covered most of
           Upper Volta in a few months, with mobile teams, and did it very
           well. They had high vaccination coverage, and measles pretty
           well disappeared.
                 Now, that was a self-serving exercise, in that we, the
           United States, wanted to test the measles vaccine on a large
           scale. Here was an area where this could be done, where it was
           desperately needed, where kids were dying of this disease, and
           you would have had to have a very, very bad vaccine indeed, not
           to be ethically justified in doing a combined trial of the
           immunization and of the vaccine itself and seeing what impact
           you would have on public health. Well, the impact was absolutely
           astounding.
                 One of the reasons that USAID [US Agency for International
           Development] was willing to go along with D.A. Henderson [Donald
           A. Henderson] and others at CDC in joining a smallpox
           eradication program, which USAID wasn't interested in, with the
           measles program, which USAID was interested in, was that they
           knew that they couldn't do much with the measles program unless
           they had some good technical support. USAID had some disastrous
           experiences without technical support, before they funded the
           full program in '66.
                 Because the United States had the measles vaccine and no
           other nation did, it was perceived that a measles immunization
           program allowed the United States an entryway into West Africa,
           where the French culture was dominant, one that did not compete
           with the French either on educational or economic grounds. But
           here was a neutral health ground-very popular concept. All the
           countries desperately wanted the measles vaccine because measles
           was such a bad disease.
                 And so I went over as one of the people to help out in the
           stages before the full program got going. I was advising OCCGE
           in running these mass immunization campaigns with measles
           vaccines.
                 Now, the French were very good at doing mass campaigns;
           there was no problem with that. The problem was that they were
           not very good at dealing with this funny, electrical jet
           injector, which we were using to administer the vaccine. And
           they were not very good at dealing with the many, many
           difficulties in supply and logistics posed by our USAID and U.S.
           Government contributions to the programs. And so, when I
           arrived, or at least one of my interviews was with the Ministry
           of Health in Upper Volta and with the Chef des Grands Endemies,
           the French advisor who was running the Grands Endemies. The
           Minister was furious because our 5 Dodge trucks that had been
           given to help administer the vaccines were consuming his entire
           budget of gasoline for his entire Grands Endemies. And the USAID
           deal was, "We give you the trucks, but you run them. You pay for
           the gasoline." And of course, that just wiped out the budget for
           the Ministry of Health for gas. All of these enormous trucks
           were consuming all the gasoline. And so he was not a happy
           person.
Harden:     Was there any solution to this problem?
Henderson:  They did the best they could. They were unhappy, but they did
           not do  a bad job with the things.  One of my problems as
           advisor was firing off cables about getting spare parts for the
           jet injectors. They kept running out of some tiny points-I
           didn't know what they were, but I think that on a regular engine
           they'd be called the points. They relate to the electrical
           system. Forget it. But that's all I knew. And I knew that they
           were burning out, and they couldn't get spare parts. So one of
           my jobs as a technical advisor, very technical, was to send
           cables back saying, "Send more of these things because they
           can't run the injectors." Nor did CDC send enough diluent, so we
           were often using Evian, one of the French bottled waters, as
           diluent for the measles vaccine.
                 I was overseas for about 6 months, traveled widely in
           those countries. I was treated extremely well by the French
           advisors, even though they knew I didn't speak very good French
           and they knew a lot more than I did about anything they cared to
           ask me about. But they were very gracious, very good about
           teaching me and helping me learn about things. I think I saw in
           those 6 months enough problems to last me the rest of my life
           about what can go wrong with an immunization program and with
           other kinds of public health programs that you're running. It
           was extremely valuable.
Harden:     One of the points that has been made over and over here is that
           medical knowledge about smallpox was really only the first step
           to eradicating it. The logistical problems, and the personnel
           problems, and the diplomatic problems, all of these things were
           key to eradicating the disease. So you were seeing this in
           advance of the project.
Henderson:  Yes, I think that's very true. I think the CDC tradition,
           though, is an important one to emphasize. We medical people went
           over with public health advisors, who joined us as nonmedical
           people, who were there exactly for the management issues. CDC
           had had a long tradition of this in the venereal disease control
           program, as it was called in the old days, and the advisors then
           branched out into tuberculosis and many other programs. There
           were always public health advisors who were trying to get the
           logistics and the management right. And so I think the CDC
           position was, "We've got to have some medical expertise to be
           credible, but we really need the management to be sure that we
           can be effective." And I think that was really the key to the
           success of much of what we did.
                 We didn't have such great medical knowledge of smallpox,
           if I can say that. The program was designed to immunize
           everybody in West Africa against smallpox, sort of a 100%
           vaccination coverage. And we didn't find out until a couple of
           years into the program that we didn't need to do that. That was
           one of the really startling breakthroughs in the program-the
           ring vaccination strategy of simply immunizing around active
           smallpox cases, breaking the cycle of transmission, and not
           going all-out to maintain high levels of immunity in all sectors
           of the population. We learned that relatively rapidly, I must
           say, within a year or so of the program. But it was a major
           conceptual breakthrough for us.
Harden:     Would you walk me through setting up the regional office in
           Lagos? You were the Deputy Director and the epidemiologist. I
           know that the Director, Dr. Lythcott [George I. Lythcott], is no
           longer alive. So will you tell me about how it was formed and
           how it functioned?
Henderson:  Well, it's a funny thing. I have very little idea about that. I
           knew that there was to be a regional office and that George was
           the Director. When I was in West Africa, and the full program
           came into being, I was then recruited from my role as an EIS
           Officer to join as the Deputy Chief of the regional office.
           George had worked in Ghana, and was a senior person, very well
           respected. It was perceived that if we were going to have a
           regional office, we should have a good regional office. And in
           the early days, as I understand it, the idea was that this would
           be the first regional office. Then, as the program expanded
           worldwide, as we got rid of smallpox in West Africa and then
           moved to other regions, there would be other regional offices in
           other regions, which were similarly constituted. In any event,
           we never did that. Ours turned out to be the only regional
           office.
                 I was there as an epidemiologist, but I was one of the few
           people who spoke French. So even though I didn't speak French
           very well, my responsibilities were mainly for looking after the
           francophone countries. My role as deputy was sort of doing all-
           hands work. We had an equipment specialist with us, a very good
           health educator, a statistician, and a secretary who was
           knowledgeable about local and embassy issues having worked  in
           West Africa before. And we also had Jim Hicks [James W. Hicks],
           our Senior Administrative Officer, who was very effective.
                 George, as the Director, dealt with all the terrible,
           terrible political problems that were really insolvable, and he
           managed to solve most of them. Jim Hicks dealt with equally
           difficult administrative problems, like who had furniture in
           their houses just in Lagos; could we get transport from the
           embassy in the early days; what was going on with the financing
           of things. He had all sorts of fights  with the embassy and the
           USAID mission, who didn't really have the resources to give the
           support that they were supposed to to our group in the regional
           office.
Harden:     Now you, as I understand, wrote most of the E-1s, the programs
           for each of the countries, in the francophone countries. Is this
           correct?
Henderson:  I don't remember that. At my age, I'm finding that happens more
           and more often. I do know that I spent some time going around
           with George Lythcott and Henry Gelfand trying to finalize and
           write what we called pro-ags, project agreements.
Harden:     Yes, that's what I meant.
Henderson:  That's right. I recently got a communication from a colleague
           who was working with us in West Africa. He sent me some of the
           letters he had sent me then. And he quoted me asking if we could
           give some of the cars that had been assigned to us, as advisors,
           to our national counterparts? And he said in the letter to me,
           "Rafe, you had already anticipated this and put the request in
           for these cars. You knew that they would be needed by the
           ministry, and that you couldn't justify it just for the
           ministry, but you would justify it by giving it to the advisors
           who were there, anticipating that they would then be shifted
           back." I have no recollection of that at all.
Harden:     There was, at this point, however, some tension between CDC
           personnel and USAID as to whom the CDC reported to-whether they
           reported to USAID, or reported to CDC through the regional
           office .  And I think it fell on you to clear the air about
           this, if my reading is correct.
Henderson:  Boy, I don't remember that either, very much. I do remember
           going to a couple of countries; my wife and I were talking about
           that. I remember being in Chad, and I was trying to recall, 40
           years later, why was I in Chad? And then it occurred to me,
           there was something going on with USAID and our staff there that
           I apparently was trying to mediate. Again, I don't remember the
           details of that. I do remember that there was a general problem
           when we from CDC came into the West African countries, and we
           felt we were masters of the universe, and there was nobody about
           to tell us what to do, certainly neither USAID nor the embassy.
            We had a mission. We were going to get our stuff done. And so
           that was a general tension that I do recall. I don't remember my
           role exactly, and what I did about it.
Harden:     You started to tell me about developing the cluster sampling
           system and the instruments we adhered to, to do the sampling.
           Would you explain, for the record, what cluster sampling is, and
           how you developed it?
Henderson:  I can, but I would also like to go back at some stage, to lead
           up as to why I ever got into that.
Harden:     Okay, let's go back. Tell me how you got into cluster sampling.
Henderson:  I had come back from India in the spring of 1967, when there
           was a smallpox outbreak. We had been expected to eradicate
           smallpox in India in a very short period of time. We did not
           succeed in doing that. My wife and I came back to CDC, and found
           that, in the interim, the Biafran War had broken out. She was
           then not allowed to go back to Lagos as a dependent. I would not
           go back to Lagos without her, and we arranged a compromise, as
           my range of responsibilities was the francophone countries
           anyhow. I did a whole series, 6 months or so, of continuous
           consultancies, firefighting, and all sorts of stuff in West
           Africa.
                 And then the Biafran War settled down, and we were able to
           go back to Lagos. I got back to my regular job, as Deputy Chief
           of the regional office. And I promptly got myself into trouble
           with headquarters because I kept feeling that the policies that
           we were being asked to follow by headquarters were not the best
           ones for us in the field and that there was not a very good
           understanding of what was needed in the field.
Harden:     And when you say headquarters, you mean here in Atlanta?
Henderson:  In Atlanta. So I became a very shrill voice, I'm afraid,
           demanding and troublesome. And I don't remember whether I was
           called back, or whether I had to come back on for another
           occasion, but when I did get back here at CDC, I was pretty well
           told, "Enough of this nonsense. We need some assessments done.
           Go do them." Again, my memory is foggy, and it may be that there
           was a lot of help, but I don't remember. What I remember was
           going off and saying, "Oh yeah. Okay. We need to do
           assessments." And it turned out to be 3 major assessments, one
           in northern Nigeria, one in western Nigeria, one in Niger. And I
           brought some reports that I'd been looking at recently, and
           trying to scratch my head, and yeah, the cluster sample survey
           was part of that assessment or evaluation. There were also
           aspects of the assessments where we reviewed records,
           interviewed people, looked at the health centers, inspected
           vaccination teams, and the rest of it. So it was a very
           extensive project.
                 Now on cluster sampling: if you do a random sample, if it
           was the Gallup polls that we do in the United States, you can
           get away with sampling a relatively tiny fraction of the
           population. But you have to do it in a very meticulous, random
           manner, so that the individual that you select is not selected
           with any bias that you can imagine. This is very intensive, very
           expensive, and very difficult to do. A compromise that was
           developed by CDC staff, Serfling and Sherman (Robert Serfling
           and Ida Sherman of CDC), here in the United States, was a
           cluster technique. And that meant that, rather than taking a
           single individual and asking questions, you could take a group
           of individuals. But if you did that, you had to compensate for
           the fact that they were a group and no longer independent. So
           one of the group had more similarities to the other members of
           the group than if you'd taken a totally different person from a
           different area because the cluster was a geographic cluster. So
           you would get households that were all together, or members of a
           household that were all together-that was the "cluster" part of
           the cluster . Rather than sampling as individual people, you
           sampled them in groups. I had learned the Serfling-Sherman
           technique as an EIS Officer. We had done a sample in Atlanta.
           Bill Foege [William H. Foege] did a modification of that in The
           Gambia early on. I knew about that.
                 So when I was asked to run these surveys, run these
           evaluations, and do a cluster survey as part of that, I further
           adapted that survey. To look back on that, it was incredible.
           How am I going to do a survey in a huge area of the country?
           What kind of a sample do I select? How do I get the records
           done? How do I collate them? I taught myself to type; I didn't
           know how to. I realized I was going to have to write these long
           reports, so I was going to have to type.
                 I realized I was going to need some way of recording the
           data. So I had worked on my own files with McBee cards-strange
           animals. I'm just going to hold up one. It's a strange card with
           a lot of holes on the sides of it. And you punch a notch in a
           hole. Each hole corresponds to something you've written on the
           card. So, for example, is this person who you're sampling a male
           or a female? Male, 1; female, 2. If they check 1, I punch 1,
           which is numbered on the edge of the card. At the end of the
           day, I get a hundred cards together, and with a sort of
           knitting needle, I run through the hundred cards, at the number
           1. And lo and behold, all the cards that have this number
           punched fall out, if I shake them vigorously enough. These cards
           were fascinating to use-difficult to use, but a godsend because
           I could then train teams, who would go out with these cards and
           then, while they were in the field, simply mark a number for
           each of the data points I had. Then at the end of the day at
           their leisure, they would take a paper punch and punch out the
           holes that corresponded to what they had found during the
           survey. Then I collected all the cards from all the teams at the
           end of the survey, went home, and spent a long time shaking
           knitting needles and having the cards fall out. And I'm sure
           there were a lot of errors involved with the things. But it was
           absolutely an incredible exercise, and I can't believe, even to
           this day, that I was able to do that, with very short notice, to
           go in, to design the cards, to decide on the sample surveys.
                 But I want to talk a little bit about the actual sample
           survey design because that was fascinating. What are you going
           to do with a population that is as varied as you have in West
           Africa? Yes, you've got some people in cities, but you've got
           people in villages. You've got people that don't particularly go
           to a village; they're nomads; they're all over the place. And,
           again, I'm just impressed with ourselves, myself, in that time.
           We designed the sample surveys to try to get if not a valid
           sample, at least an idea of these various groups.
                 So, for example, we could have a sample survey that said,
           let's take a valid statistical survey of all the villages in a
           catchment area, or a state, or a country, that are under 5,000
           population. Perhaps we thought under 5,000 would be a high-risk
           group for smallpox. We'd get all the villages. So you select,
           say, 30 villages out of those. And then we said, "You get your
           sample from that village but then leaving the village, for the
           next 10 kilometers, you stop every person you see, and you
           interview them-no matter who they are, or what they're doing."
           And then we said, "In addition to that, you go to some of the
           local markets, and you do a market survey and find out who's
           there. And within the market, sometimes you can select
           individual groups." We knew there were nomadic tribes, and we
           could recognize them because they wore distinctive things. So we
           could say, "Survey 10 of the nomads from this area, and 10 from
           that area."
                 In western Nigeria, we had an area of the state that was
           very heavily influenced by fetisheurs, by the traditional
           healers. And we knew that they had a cult, the Shapona or
           smallpox cult, that did not appreciate being vaccinated against
           smallpox. They were against vaccination. And we knew that
           vaccination coverage was lower in that area than in other areas.
           So we did a separate sample of the fetish area and the nonfetish
           area.
                 We did all sorts of tricks to try to probe where we were
           weak. It wasn't so much that the sample was going to give us a
           wonderful average of what was going on in the country, but my
           idea was, let's point the finger at where we think we're doing
           least well. Let's find out what's going on there; that's where
           we need to make the changes. It was just a fascinating
           experience. As I said earlier, the survey was only part of the
           full assessments we did.  We also looked at records, we
           interviewed people, we inspected vaccination teams.
                 We found faults everywhere. There were problems
           everywhere. And that was one of the great lessons that I learned
           in my life-despite all the problems that you find every day, and
           despite the fact that you think nothing's going well, that isn't
           always the case. You can have some success despite it.
                 The other thing that was impressive looking back now on
           this, is that there was no stopping us. I mean, getting a sample
           survey, doing these assessments, that's no problem. We'll just
           do it. And I think it was the attitude of the entire program. We
           had a goal; we were going to do it; nothing was going to stop
           us.
                 I'll tell you 1 other anecdote that illustrates that. We
           got stuck in western Nigeria during one of these assessments. We
           got often stuck in western Nigeria. It was during the rainy
           season, and we spent more times pulling ourselves out of mud
           holes than anything else. But we were in a rubber plantation,
           for reasons I don't understand, but we were doing a survey
           there. And it turned out that the vehicle was running down on
           hydraulic brake fluid. The brake pedal kept getting weaker and
           weaker. And we knew when we left in the morning that we needed
           some extra fluid. We had some, but by the middle of the day, it
           was getting low, and we were running out. And we finally looked
           under the hood and found that the brake line was rubbing against
           the engine, and it had cut a little hole in the hydraulic line.
           And I said, "Right, okay. I know how to do that from an intern
           in Boston City Hospital. Give me some tape, and I'll tape it
           up." I taped it up. But each time I did it, because the brake
           line has a lot of pressure it just blew the tape away. It didn't
           work at all. We were down to our very last little bit of
           hydraulic fluid, and I said, "Right. What am I going to do?" And
           we got some cotton that we had for first aid. I took some sap
           out of a rubber tree, chewed the sap into the cotton to make it
           a solid compress, and tied a whole series of very tight suture
           knots around the hydraulic line. Amazingly, the thing held 'til
           we got back at the end of the day. But that was the attitude:
           "This isn't going to stop us. We can fix this. Nothing is going
           to stop us." And that happened over and over and over again, to
           everybody in the program. It was incredible. And I think it was
           one of the things that made the program just such a success.
           People would not be stopped.
Harden:     Now, do a little analysis here. Was it just because these
           particular people were so special? Was it an American thing? Was
           it inspiration from above? What do you think made this group?
           Obviously, it's a very special group. Do you have any opinions
           on this?
Henderson:  I hesitate to say it, but I'll say it anyhow. It's not a very
           special group. And I think that's the magic of it. Special in
           that the challenge was there, yes. Good leadership. Good
           support. A strong image of what needed to be done. But by God,
           when you do that, and you give people responsibility and things
           that they've never met before, most times, most people will rise
           to that challenge. And I say that because I then had experiences
           later in life, in the World Health Organization (WHO), or other
           programs, where we had the same sort of thing. We had specific
           goals to achieve and people from many cultures, many different
           backgrounds, still rising to that challenge in an extraordinary
           way.
                 And don't forget, as I'm sure that nobody will, that we
           were a tiny fraction of those who did the work. Most were the
           nationals -  the vaccination teams, the staff, the people living
           in the endemic villages. So let's be clear that we were helpers
           in a project that was done largely by national staff.
Harden:     Were there any particular problems in dealing with the national
           staff that you recall or were there good relations from start to
           finish?
Henderson:  I would have to say mixed. I think the relationship got better
           as we all got more familiar with the environment and the
           cultures with which we were dealing. When we arrived, we, the
           CDC people, fresh out of the U.S., were impatient. We didn't
           understand why something couldn't be done yesterday; what was
           the problem? And of course, the folks we were dealing with-
           whether it were the national ministries of health, the French or
           English advisors who were there, the other expatriates-they
           thought we were nuts when we first arrived. They couldn't
           understand why we were having these expectations. Many of the
           French thought that the word "eradication" should be eradicated.
           They had very little little time for this eradication concept.
                 And so, yes, there were a lot of tensions with that. But I
           would have to say, again, that the experience of the public
           health advisors-who had dealt with those kinds of issues in the
           United States with state and local health departments and
           recalcitrant public officials at all levels and learned to find
           ways of getting things done so that everybody went along with it-
           these types of situations are where they really shone. We in the
           medical officer field were often not so good at that, and I
           think we were very well served by having the public health
           advisors with us.
Harden:     In December 1969, there was an observance of the hundred
           millionth vaccination in Niger. Were you involved in that at
           all, and do you have any special memories of that event?
Henderson:  That was in Ghana, and I have some memories of it. I wasn't
           involved with the organization of the event, thank goodness,
           because it was a massive affair. But I do remember going and
           giving an interview to the Ghanaian newspaper about things. The
           report of the interview in the press talked about our work in
           eradicating rabies or malaria, or something totally not having
           anything to do with what I had said or what the program was
           about. One of the reasons I was doing that interview was that, I
           think the Minister of Health and George, the Director of the
           program, were off doing the hundred millionth observance, and
           they needed somebody to satisfy the local news media who could
           speak about the program. So my role was a very minor one. But it
           was a grand affair.
Harden:     If you were going to do the program all over again, would you
           change anything about the way it was run?
Henderson:  Given that it worked, I think not.
Harden:     How did the smallpox eradication program change your life and
           career, or did it?
Henderson:  Oh, very much. When I came to CDC, my idea was to work in
           public health for a while, go back to internal medicine, and
           maybe get a joint accreditation in public health and internal
           medicine, as many of my colleagues were doing. But when I got to
           West Africa and had a little bit of experience there, 2 things
           happened. One, I was addicted to public health. Two, I knew I
           had to go back and get some management training. So I applied to
           the Director of CDC, Dave Sencer, and asked him for a career
           development extension to go back and get a degree in public
           health at Harvard Medical School. And I said, "I know Harvard. I
           will look during that first year at the School of Public Health
           and I will find some management training I can do during the
           second year."   I was sitting in Lagos, so I couldn't tell
           Sencer exactly what that second year was about, but I said it
           would be management. And, in fact, I tried to get into the
           Harvard business school, but they had a very rigid program that
           I thought was very unhelpful. The Kennedy School was just
           starting a program of Master of Public Policy. They wouldn't let
           me into it because they said I was too old. I think I was 28 or
           29. I insisted that I was just the right person and talked my
           way into it. So that was my second year of training.  So it did
           change my life in a radical way.
Harden:     What impact do you think the program had? What impression did
           it leave in Africa about the United States, about CDC? Do you
           think it had an impact on the end?
Henderson:  I think it was good. I mean, it may have been astounding. When
           you're working down in the guts of an organization, one doesn't
           see the perspective of what others have about the whole range of
           things. I don't think we left a bad impression, by any means.
           But that was nothing I was aware of, or got feedback on.
Harden:     You said your wife was traveling with you. What impact did the
           smallpox eradication effort have on your marriage, in terms of
           anything? Traveling?
Henderson:  Well, we were unusual. We had just gotten married. My wife is a
           pharmacist, and we didn't have kids. And I thought that she
           could be extremely helpful in what I was doing. Sample surveys
           are not difficult to do. Keeping the records, drawing maps,
           things of that sort, she does very well, and so we worked as a
           team. And we continued to travel wherever we could as a team,
           together. Now, she wasn't paid by anybody. I paid for whatever
           travel was going on, but we worked together all the time. And in
           fact, when I think about it now, it set an unusual precedent. We
           kept running into problems later in life, when she would sit in
           on staff meetings, or go to meetings with other organizations,
           and they would say, "What's your wife doing here?" Well, there
           would be administrative assistants, other people who would not
           be contributing from a professional perspective but would be
           sitting and listening in.  But the fact that she was a wife
           alienated a lot of people. Eventually, she began introducing
           herself as my personal assistant. That seemed to work a lot
           better. But it had a very strong bonding affect on our marriage
           and lasted throughout our professional lives and through the
           present..
Harden:     Before we stop, is there anything else about the Smallpox
           Eradication Program that you think of, that we should discuss?
Henderson:  I think that one of the extraordinarily important legacies was
           the group of people. Now, I have just told you that the group of
           people was not extraordinary, that they were ordinary people.
           But having gone through that experience, many of them continued
           on working together as colleagues throughout their careers. And
           the smallpox program in West Africa morphed into the larger
           global program, with many of our staff from West Africa joining
           the global smallpox eradication program and having major roles
           in that.
                 After spending some time at Harvard and back at CDC, I
           went back to WHO in 1977. I had left West Africa in '69. So
           almost a decade later, I came back to international health at
           the recommendation of Dave Sencer, to go and replace D.A.
           Henderson at WHO and to run what was then a new program, the
           Expanded Program on Immunization, which was a child of the
           smallpox program.
            Even in the smallpox days, we were looking at how to use other
           vaccines with smallpox vaccine, how to do combined
           immunizations. So a lot of the science had already been done by
           us in West Africa, plus other colleagues elsewhere that were
           working on the same issue. When smallpox success seemed assured
           in 1974, the Expanded Program on Immunization was adopted by
           WHO. The idea was to take what we knew about the smallpox
           experience, providing immunizations for a disease, and do a
           childhood immunization program. The program faltered for a
           couple of years, and I was called in  both because the program
           was faltering and D.A. who everyone assumed would take over the
           program decided to leave WHO.  There was a desire on the part of
           the U.S. to have a CDC US person replace D.A. and I went back to
           do that.
                 Now, when I went back, a lot of the "mafia" I worked with
           were the smallpox mafia-both the smallpox mafia that we had in
           West Africa and the larger mafia that was then created when the
           global program was created because the global smallpox program
           was just phasing out. So suddenly I had a whole large staff of
           people who had that same motivation, who had that same
           perspective, coming into my program now, into the Expanded
           Program on Immunization. They continued on to do polio
           eradication, the diarrheal disease program, a whole slew of
           very, very important public health initiatives. And that came, I
           think, directly from this initiative in West Africa, the
           smallpox group, then going to the larger, international group,
           and then the international group coalescing around several
           extremely important public health programs.
Harden:     Do you think there will be another disease we can eradicate?
Henderson:  Well, we're certainly trying with polio.
Harden:     And having some very difficult problems, I think, and
           discussions about whether it will be done.
Henderson:  Yes. It's a very interesting quandary in public health because
           you don't know, when you're beginning, if you're going to
           succeed. If you knew that, it wouldn't be a problem. You'd just
           get it done. We didn't know when we did smallpox in the
           beginning that we would succeed. In fact, we had to change the
           program radically in order to succeed. The same is happening
           with polio-major, major technical breakthroughs, change your
           philosophy, change of the way we approach things-learning as we
           go, and having a lot of problems on the way. But that's the way
           you make progress in science. That's the way you get better.
           Now, there may come a day when we say, "Okay, enough is enough.
           We've got to call it quits." But until that very end, I think
           it's absolutely well worth giving it the best shot that we can.
            Malaria was a situation where we tried and tried, and then it
           became increasingly apparent that this was not going to work. We
           didn't have the science. We didn't have the technical skills or
           the technical equipment to do the job. We had to change the goal
           of the program. That's not happened with polio, yet. We have a
           lot of good irons in the fire, and I don't think we should be
           anywhere near giving up at this time.
            But there will also be interest in eradicating measles; there
           will be interest in eradicating other diseases. When I did the
           Expanded Program on Immunization, coming in in '77, people in
           WHO said, "OK Rafe, we know who you are. You're one of these
           eradication people. You are just interested in the short term."
           And I said, "Not on your life. I'm not interested in
           eradication. I'm interested in long-term childhood
           immunization."
            But I was interested in eradication. And I came back to that in
           the late 1980s, when our routine immunization had more or less
           done what it could do. It was reaching levels that were not too
           bad but were also not too good. And at that point, we adopted
           polio eradication, not only because we thought we were ready for
           it but also because the polio eradication effort was 1 thing
           that stiffened us up in the other efforts. Because we were
           dealing with a specific disease, that helped us do the rest of
           the things, gave us more enthusiasm for doing those other
           things, as well. And I do think that the occasional disease-
           specific initiative, whether it's eradication or radical control
           of a disease, can help strengthen a larger health initiative, or
           set of initiatives, and will remain a useful public health
           strategy as long as we have both the combination of large,
           integrated services that we're doing and some specific things
           that are within those integrated services. I think that
           combination remains extraordinarily important in public health
           and probably in other enterprises as well.
Harden:     Thank you so much for speaking with me. I think we've got some
           fine footage here. I am delighted about the details on the
           cluster sampling system. Nobody else has provided anything on
           that for me, so I'm very pleased to have that.
Henderson:  Good.
###
&lt;/pre&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="86">
          <name>Player</name>
          <description>html for embedded player to stream video content</description>
          <elementTextContainer>
            <elementText elementTextId="65094">
              <text>&lt;iframe width="560" height="315" src="https://www.youtube.com/embed/FlQOn2USRvU" frameborder="0" allowfullscreen&gt;&lt;/iframe&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42934">
                <text>interviews</text>
              </elementText>
              <elementText elementTextId="42935">
                <text>motion pictures</text>
              </elementText>
              <elementText elementTextId="42936">
                <text>moving image</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42937">
                <text>2006-07-07</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="42938">
                <text>http://pid.emory.edu/ark:/25593/15ncv</text>
              </elementText>
              <elementText elementTextId="42939">
                <text>emory:15ncv</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42940">
                <text>Smallpox Eradication</text>
              </elementText>
              <elementText elementTextId="42948">
                <text>Survey</text>
              </elementText>
              <elementText elementTextId="42949">
                <text>Cluster sampling</text>
              </elementText>
              <elementText elementTextId="42950">
                <text>Surveillance</text>
              </elementText>
              <elementText elementTextId="42952">
                <text>USAID</text>
              </elementText>
              <elementText elementTextId="42953">
                <text>WHO</text>
              </elementText>
              <elementText elementTextId="42954">
                <text>CDC</text>
              </elementText>
              <elementText elementTextId="42955">
                <text>Expanded Programme on Immunization</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42941">
                <text>10852080000 bytes</text>
              </elementText>
              <elementText elementTextId="42942">
                <text>video/x-dv</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42943">
                <text>Henderson, Ralph (Interviewee); CDC</text>
              </elementText>
              <elementText elementTextId="42944">
                <text>Harden, Victoria (Interviewer)</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42945">
                <text>Centers for Disease Control</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42946">
                <text>HENDERSON, RALPH "RAFE" </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42947">
                <text>Dr. Henderson was Deputy Director of the West African Smallpox Program, stationed in Lagos in the Regional Office.  He was responsible for the on the ground epidemiologic aspects of the program and developed methods of evaluation that have served in a multitude of other programs.  He was subsequently assigned to WHO to initiate and direct the Expanded Immunization Program, and was an Assistant Director General of WHO.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="42951">
                <text>English</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
</itemContainer>
